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Pharmaceuticals and personal care products in New Hampshire: prevalence and the influence of 
microbial communities on removal during wastewater treatment 
By 
Carmela Antonellis 
University of New Hampshire, September 2021 
Pharmaceuticals and personal care products (PPCPs) represent a class of 10,000+ emerging 
contaminants that are widely used in communities for a variety of medical, health, and care 
applications. Many PPCPs are biologically active compounds, are typically unregulated in 
drinking water and surface waters, and may be incompletely removed in our municipal wastewater 
treatment systems. Understanding the sources and fate of PPCPs in the environment is important 
to protecting ecosystems because some compounds may pose toxicity or result in behavioral 
impacts to aquatic species. This thesis evaluated the presence and concentration of PPCPs in 
surface water sample locations in New Hampshire's Great Bay Estuary. It also investigated PPCP 
removal in context with the microbial community diversity and metabolic for potential in four 
municipal wastewater treatment facilities (WWTFs) discharging to tributaries of the Great Bay 
Estuary. Microbial community composition of secondary wastewater samples was assessed 
through sequencing the 16S rRNA biomarker gene while microbial metabolic potential was 
evaluated through metagenomic sequencing. Nonmetric multidimensional scaling analyses was 
used to evaluate drivers for water quality changes and PPCP removal based on 16S rRNA amplicon 
sequence variants in Qiime. Pathways for PPCP biodegradation were elucidated from 
metagenomic data using MG-Rast and KBASE.  Results reveal bacteria as the dominant microbial 
domain in each WWTF, with Proteobacteria, Bacteroidetes, Actinobacteria, and Firmicutes as the 
 vi 
most dominant phyla.  Xenobiotic biodegradation and metabolism accounted for less than 2% of 
all metabolic activity at each WWTF.  This research advances our understanding of the occurrence 
and fate of PPCPs during wastewater treatment.
 1 
CHAPTER 1 
Background and Motivation 
Pharmaceuticals and Personal Care Products as Compounds of Emerging Concern 
It is well known that anthropogenic activity and human waste have posed a threat to the natural 
environment for many years (Tang et al. 2016).  Pharmaceuticals and personal care products 
(PPCPs) are biologically active compounds that pose a potential risk to ecosystem and human 
health (Gaffney et al. 2017, Baran et al. 2011, Liu et al. 2018) due to their incomplete removal in 
wastewater treatment (Blair et al. 2015, Gago-Ferrero et al.  2017, Golovko et al. 2014, Jelic et al. 
2011, Sörengård et al. 2019), increasing human consumption (Jelic et al. 2011), and frequent 
detection in wastewater streams and natural ecosystems around the world (Dubey et al. 2021, 
Halling-Sorensen et al. 1998, Kummerer et al. 2009).  The global scientific community has come 
to a consensus that PPCPs are ubiquitous in wastewater treatment facilities (WWTFs), and thus in 
wastewater effluent entering receiving water bodies (Golovko et al. 2021, Pomiès et al. 2013).  We 
have yet to identify the thousands of pharmaceutical compounds and personal care products that 
are suspected to exist in the environment (Yin et al. 2017).  Therefore, these compounds are 
recognized as contaminants of emerging (CECs) concern across aquatic matrices (Kovalakova et 
al. 2020).   
 
Human consumption of PPCPs shows an increasing trend (Baran et al. 2011), and currently there 
are no legal regulations concerning the concentrations of micropollutants and CECs entering the 
natural environment via WWTF effluent in the United States (Angeles et al. 2020, Liu et al. 2018).  
There are also no regulations restricting antibiotic concentrations in wastewater effluent 
 2 
(Kovalakova et al. 2020).  These compounds are constantly being discharged into receiving water 
bodies (Yin et al. 2017, Archer et al. 2017), and are usually reported in the range of ng/L to ug/L 
concentrations (Archer et al. 2017, Golovko et al. 2021). Contaminants of emerging concern can 
exhibit toxic effects on non-target organisms and bioaccumulate in the environment (Meyer et al. 
2019, Petrie et al. 2015, Sörengård et al. 2019), causing concern regarding their presence in aquatic 
environments.   
 
Although there are multiple sources for PPCPs entering the natural environment, this review 
focuses on the effluent of municipal wastewater treatment facilities (WWTFs) because these 
facilities are regarded as major dischargers of micropollutants to receiving water bodies (Angeles 
et al. 2020).  There are many sources from which these compounds originate, including human 
excretion, pharmaceutical industries, hospitals, and incorrect disposal (Archer et al. 2017, 
Kovalakova et al. 2020).  Runoff from livestock manure into surrounding ecosystems and 
discharge of landfill leachate into municipal WWTFs are also considered sources for these 
micropollutants (Yin et al. 2017, Kovalakova et al. 2020, Archer et al. 2017, Bilal et al. 2020).  
Figure 1.1 shows the main sources of PPCPs entering WWTFs and entering the natural 
environment.  Although some technologies may be efficient when it comes to removing 
pharmaceutical residues, secondary treatment was not originally designed with these compounds 
in mind (Angeles et al. 2020).  In order to fully understand the risks that PPCPs present in the 
natural environment, more research is needed regarding the occurrence of PPCPs, their toxicity, 
and the fate of both the parent compound and their transformation products (Yin et al. 2017). 
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Figure 1.1: The main sources, domestic and industrial/commercial, of PPCPs in WWTFs and their routes to the natural 
environment.  Taken from Yang et al. 2017. 
 
Pharmaceuticals and Personal Care Products Detected in WWTFs and in Surface 
Water 
Pharmaceuticals and personal care products (PPCPs) have been detected in aquatic matrices in 
addition to being detected in WWTFS (Dubey et al. 2021, Hidrovo et al. 2020, Kovalakova et al. 
2020) indicating that they are being released into the natural environment (Sörengård et al. 2019).  
Wastewater treatment facilities have been noted as main routes for contaminants of emergence 
concern into aquatic matrices (Sörengård et al. 2019).  It is important to note that WWTFs are not 
necessarily original sources for PPCPs, but rather the conduits for these compounds to enter the 
natural environment.  Routes for PPCPs in environment include the direct discharge of effluent 
(also known as treated wastewater) into aquatic ecosystems, the use of effluent to fertilize soil, and 
the use of sludges as soil amendments (Garcia-Santiago et al. 2016).  The continued use of 
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biosolids for agricultural purposes has been found to increase the presence and concentration of 
PPCPs in soils (Garcia-Santiago et al. 2016).  The season, as well as the location of the WWTF, 
can influence the concentration of PPCPs detected in surface water (Archer et al. 2017). 
 
Depending on the type of pharmaceutical compound, it may be metabolized anywhere from 10% 
up to 90% before excretion from the human body (Kovalakova et al. 2020).  Once excreted, the 
compound enters the municipal wastewater stream then flows to the local WWTF.  The constant 
use of PPCPs, as well as the inefficient removal of these compounds in WWTFs, means that 
aquatic organisms are regularly exposed to PPCPs (Angeles et al. 2020, Yin et al. 2017, Liu et al. 
2018). Many antibiotics, a pharmaceutical class of PPCPs, are water soluble, and therefore 
persistent in the environment (Liu et al. 2018).  Antibiotics have been detected in seawater, surface 
water, ground water, and even drinking water (Bilal et al. 2020).   
 
Antibiotics are typically found in concentrations of tens or hundreds of ng/L in aquatic ecosystems 
(Kovalakova et al. 2020) and can have negative impacts on the food chain (Liu et al. 2018).  
Sulfonamide antibiotics, a specific category of antibiotics, can bioaccumulate in food chain 
organisms and also have the potential to impact the development of plants and plant growth. (Baran 
et al. 2011).  Bioaccumulation of sulfonamides in the food chain can increase the toxic effects seen 
in non-target organisms (Baran et al. 2011).  Kovalakova et al. (2020) classified Sulfamethoxazole, 
a type of sulfonamide antibiotic, as a very toxic compound to photosynthetic organisms.  The most 
sensitive biological entities were aquatic plants, cyanobacteria and algae (Kovalakova et al. 2020). 
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It is crucial to note that many of the metabolites and transformation products of PPCPs that may 
arise during wastewater treatment remain unknown, as well as their toxicity on non-target 
organisms (Yin et al. 2017).  It is therefore important to evaluate the removal of these compounds 
from WWTFs due to their potential to harm aquatic organisms, including their chronic toxicity.  
Chronic toxicity indicates a low dose of a chemical over a long period of time, which is a much 
more realistic picture of what is happening in aquatic environments (Golovko et al. 2021).   
 
Antibiotic Compounds 
Antibiotics are natural, semi-synthetic, or synthetic compounds that are used to fight bacterial 
infections and inhibit bacterial growth in humans and animals (Bilal et al. 2020, Liu et al. 2018).  
Compounds with antibacterial properties are used widely in animal husbandry for the prevention 
and cure of diseases, as well as the promotion of animal growth (Liu et al. 2018).  Due to their 
wide consumption, as well as their environmental persistence, antibiotics are also regarded as 
compounds of emerging concern (Bilal et al. 2020, Liu et al. 2018, Archer et al. 2017).  Similar to 
PPCP consumption, antibiotic usage is increasing worldwide (Kovalakova et al. 2020).  Owing to 
this increase as well as the inefficient CEC removal in WWTFs, antibiotics are typically detected 
in the environment in ng/L to ug/L (Kovalakova et al. 2020, Liu et al. 2018).  Large amounts of 
these drugs are detected in the aquatic environment because they are incompletely metabolized in 
humans and animals and inefficiently removal in wastewater treatment (Baran et al. 2011, Liu et 
al. 2018).  Therefore, antibiotic parent compounds and their associated metabolites are commonly 
released into the environment (Bilal et al. 2020).  Antibiotics are not fully metabolized by the 
human body nor in animals, thus they are excreted in urine and feces as an unchanged compound, 
in the form of a sulphuric or glucuronic acid conjugate, or as a metabolite (Kovalakova et al. 2020).  
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This constant presence of antibiotics potentially poses a threat to aquatic organisms as well as 
humans. 
 
Antibiotics are of particular concern due to the impacts they can exert on non-target organisms.  
Figure 1.2 exhibits the toxicity of eight different antibiotics on different aquatic organisms.  Many 
studies indicate that antibiotics are not effectively being removed in conventional wastewater 
treatment, thus they are considered poorly degradable compounds (Bilal et al. 2020, Kovalakova 
et al. 2020).    Golovko et al. (2021) found that most of the antibiotics included in their study, 
including amoxicillin, azithromycin, ciprofloxacin, sulfamethoxazole, and trimethoprim, 
displayed insignificant removal efficiencies.  This was also true for the antidepressants included 
in the study, including fluoxetine (Golovko et al. 2021).  Additional studies have also observed 
incomplete removal trends for PPCPs (Bendz et al. 2005, Gobel et al. 2007, Kasprzyk-Hordern et 
al. 2009).  However, there is some micropollutant removal occurring during wastewater treatment.  
Removal of antibiotics during the secondary treatment process can occur through either 
biodegradation of the compounds by microorganisms, or via sludge adsorption (Kovalakova et al. 
2020).  The pathways regarding PPCP removal in wastewater treatment will be discussed further 
in this review.   
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Figure 1.2: The Ecotoxicity of eight antibiotics towards different organisms, compiled from a review of the current 
literature, indicating that even low concentrations of antibiotic compounds can exhibit significant toxicity.  Figure 
retrieved from Kovalakova et al. 2020.   
 
Sulfonamide Antibiotics 
Sulfonamides are a group of antibiotics that are known as synthetic drugs, with bacteriostatic and 
antibacterial properties (Baran et al. 2011).  They are effective against both gram-negative and 
gram-positive bacteria and may also be used against fungi and protozoa.  Sulfonamides have been 
administered in animals since the 1940s and are also used often in humans (Baran et al. 2011).  
Baran et al. (2011) reported that over 80% of sulfonamides are excreted via waste from humans 
and animals as unchanged compounds.  Sulfonamides are of concern due to their wide use and 
presence in the environment (Baran et al. 2011).  They are detected frequently in the environment 
and are suspected to be hazardous to human health and the receiving water’s microbial 
communities (Baran et al. 2011).  There is concern regarding even low concentration of 
sulfonamides in the environment because they have a high biological activity.  This means that 
trace amounts of sulfonamide antibiotics have the potential to greatly alter the biosphere (Baran et 
al. 2011).  Additionally, sulfonamides have even been reported to occur in 27% of all streams and 
rivers in the United States, and in most of the surface waters tested for the compounds in Taiwan 
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and France, as well as in 1005 wastewater samples in one study by Baran et al. (2011) (Baran et 
al. 2011).  Not only is current research concerned with the toxicity and effects of sulfonamides in 
aquatic organisms, but there is also worry with regard to sulfonamides exhibiting synergism.  
Synergism is used to describe the toxicity levels caused by a mixture of pharmaceutical 
compounds, (Baran et al. 2011) and remains an understudied area of research within the field 
CECs. 
 
Removal of Pharmaceuticals and Personal Care Products in Wastewater Treatment 
As stated earlier in this review, PPCPs are commonly released into the natural environment via 
WWTF effluent (Golovko et al. 2021, Kovalakova et al. 2020, Yin et al. 2017).  Activated sludge 
(AS) is a type of secondary, biological treatment process utilized in many WWTFs to reduce the 
concentration of various nutrients, including carbon, nitrogen, and phosphorous, as well as 
chemical oxygen demand (COD).  Although the AS process does decrease the concentrations of 
some pharmaceuticals, the process is not always efficient in removing these contaminants (Angeles 
et al. 2020, Archer et al. 2017, Bilal et al. 2020, Kovalakova et al. 2020, Yin et al. 2017).  Many 
factors impact PPCP transformation and fate in wastewater treatment, which can be seen in Table 
A1.1.  The main removal mechanisms, that is aqueous phase removal for PPCPS in wastewater 
treatment, include biodegradation via microorganisms, sorption to sludges, and volatilization 
(Pomiès et al. 2013). 
 
Pollutant Fractionation in Wastewater Treatment 
The main routes of PPCP removal discussed in the current literature include microbial degradation 
(also known as biodegradation) (Jelic et al. 2011, Joss et al. 2006, Ternes et al 2004), sorption to 
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sludge/solids (Jelic et al, 2011, Joss et al. 2006, Ternes et al. 2006), chemical transformation (Jelic 
et al. 2011), and volatilization (Joss et al. 2006).  Due to the nature of many PPCPs, volatilization 
is not regarded as a significant removal pathway (Joss et al. 2006). The removal of PPCPs in 
wastewater treatment can vary greatly (Jelic et al. 2011, Miege 2009, Oulton 2010, Verlicchi 
2012).  Compounds that belong to the same pharmaceutical class do not exhibit similar sorption 
behavior.  This is because compounds within the same class can vary greatly in their 
physicochemical properties (Hörsing 2011). 
 
In a study evaluating the removal efficiencies of PPCPs in a South African WWTF, Archer et al. 
(2017) found varying removal efficiencies, including negative removal for one antibiotic, one anti-
depressant, one anticonvulsant, and two analgesics (Figure 1.3).  In multiple studies, contaminants 
of emerging concern were found in significantly high concentration in sludges (Camacho-Munoz 
et al. 2012, Golovko et al. 2021).  These findings support the theory that compounds are at least 
partially sequestering in sludge during wastewater treatment.  The partition of PPCPs to sludges is 
cause for concern because sludges are often applied to for land uses (Dubey et al. 2021), including 
as fertilizer and soil amendments (Golovko et al. 2021, Luo et al. 2014, Yang et al. 2017).  Even 
though sludges are processed prior to use, the contaminants remaining in land-applied sludges may 
runoff into the surrounding aquatic ecosystems (Golovko et al. 2021).  Sludges that are not applied 
for land use may be incinerated or disposed of through landfilling, which can percolate into 
groundwater sources (Golovko et al. 2021).  
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Figure 1.3: The percent removal efficiencies for PPCPs in a South African WWTF.  Figure retrieved from Archer et 
al. 2017. 
 
A study by Golovko et al. (2021) focused on evaluating the presence of CECs in wastewater.  The 
study concluded that the removal efficiency for the 164 compounds evaluated in the study greatly 
varied.  On average, the total concentration of CECs from influent to effluent decreased 60%.  
Previous studies also concur with this result (Fick et al. 2011).  The field of wastewater treatment 
needs dedicated research towards understanding the removal efficiency of PPCPs, as well as the 
impact these compounds have in the receiving ecosystems (Golovko et al. 2021) 
 
Predicting PPCP Behavior during Wastewater Treatment 
While there are many approaches used to determine the behavior PPCPs may exhibit during 
wastewater treatment, there are two compound-specific variables that are commonly used; the 
partition coefficient (KD) and the octanol-water partitioning coefficient (Kow).  KD has been termed 
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a sorption coefficient, as it is used to describe a compound’s ability to sorb to solids or sludge, 
while Kow is often described as the hydrophobicity of a molecule (Pomiès et al. 2013).  The 
partition coefficient KD is calculated as the division between the sorption kinetic constant and the 
desorption kinetic constant of a compound, chemical, or metal (Pomiès et al. 2013).  In other 
words, the KD of a pollutant is defined as the dissolved concentration multiplied by the liqueur 
suspended solids concentration, divided by the fraction of the pollutant that is sorbed to solids 
(Pomiès et al. 2013).  Sorption and desorption can take place simultaneously, and sorption can 
describe an aqueous (dissolved) or solid phase of a compound (Pomiès et al. 2013).  While the KD 
values of PPCPs are experimentally determined, it is important to stress that these values may 
change based on the matrix utilized (such as activated sludge, sediment, or soil) and environmental 
conditions (including pH, carbon content, oxygen content, and temperature) (Pomiès et al. 2013).  
This causes high variability in KD values for PPCPs and difficulty in predicting compound 
behavior (Pomiès et al. 2013).  Despite this variability, researchers still suggest that KD is useful 
in indicating a compound’s removal efficiency (Pomiès et al. 2013). Both of these coefficients 
have been used to predict PPCP behavior during wastewater treatment.   
 
Compounds that are more water soluble have low values for KD and Kow (Golovko et al. 2021).  It 
has also been suggested that compounds with a log KD less than 2.5 have a higher likelihood of 
partitioning to the aqueous phase, while compounds with a log KD greater than 3.2 have a higher 
likelihood of ending up in the solid phase (Luo et al. 2014).  Although, it should be noted that 
some researchers have not observed a correlation between removal efficiency and log KD (Govolko 
et al. 2021).  A study by Dubey et al. (2021) found that chemicals that have a log KD value less 
than 2 have a lower ability to adsorb to sludge, while chemicals that have a log KD greater than 4 
are removed via sorption at significant levels.  Thompson et al. (2011) observed that significant 
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compound removal occurred when a compound had a log Kow greater than 4.0.  Additionally, 
temperature and pH have been noted to impact sorption potential described by the KD variable 
(Dubey et al. 2021).  Temperature decreases can cause compounds to have higher KD values, which 
may result in a higher sorption of a pollutant to sludge (Dubey et al. 2021).  It is also worthy to 
note that the octanol-carbon distribution coefficient, also known as Koc, can be used to evaluate 
how a compound may sorb to sludge depending on its organic carbon content (Dubey et al. 2021).  
While many studies have investigated the use of KD, Kow, and even Koc, to predict PPCP behavior 
and partitioning to sludge, this is still a developing field of research as the partition coefficients 
for PPCPs can vary greatly based on the media to which sorption is evaluated, and the fact that 
there is such a wide array of PPCPs in wastewater that need to be evaluated. 
 
Factors Influencing Sludge Partitioning 
While there is a wide array of factors impacting the removal and degradation of PPCPs in 
wastewater treatment, there are some factors that have a significant influence on how these 
compounds partition to sludges in secondary wastewater treatment.  Physicochemical properties 
of PPCPs, including molecular weight, acid dissociation constant (Pka), and the octanol water 
partition coefficient (Kow) have been noted to influence how likely a compound is to partition to 
sludge during secondary treatment.  Oxidation-reduction conditions may also be involved in 
sorption (Pomiès et al. 2013).  It is also possible that by increasing solids retention time (SRT), 
microbial diversity is encouraged by allowing slower growing organisms to thrive, which may 
increase the potential for biodegradation (Kreuzinger et al. 2004, Suarez et al. 2010).   
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Micropollutants may sorb to sludge as “dissolved-colloidal particles” based on the composition of 
the sludge (Dubey et al. 2021).  The influential sludge properties can include aromatic properties, 
physical properties (such as density), the degree to which the sludge is oxidized, and sludge protein 
content (Dubey et al. 2021).  It has also been proposed that a longer hydraulic retention time (HRT) 
may increase pollutant removal because it increases the contact time that microorganisms have 
with wastewater containing PPCPs (Pomiès et al. 2013).  A full list of the factors described to 
influence PPCP removal during wastewater treatment can be seen in Table A1.1, along with their 
corresponding references. 
 
Research has mainly focused on the aqueous concentrations of micropollutants (Jelic 2011), 
perhaps because sludge is such a complex matrix.  Micropollutants, including pharmaceuticals, 
have been found in sludges (Lillenberg et al. 2009, Lindberg et al. 2010, McClellan and Halden 
2010, Radjenovic et al. 2009), and sometimes in elevated concentrations (Dubey et al. 2021).  A 
survey by the U.S. Environmental Protection Agency surveyed WWTFs around the country and 
found that there were 145 emerging contaminants detected in the sludges from 74 WWTFs.  
Concentrations were found up to several hundred parts per million, or mg/L (Venkatesan et al. 
2015).  Nations, including the United States, need to regulate the reuse of biosolids to address 
emerging micropollutants (Garcia-Santiago et al. 2016).  There is limited information regarding 
micropollutants like PPCPs, as well as the lack of a homogeneous methodology to evaluate PPCP 
sorption to sludges (Pomiès et al. 2013).  Inadequate data on micropollutant behavior during 
wastewater treatment hinders the environment policies and regulations that require this 
information to implement PPCP concentrations in wastewater biosolids and effluent (Dubey et al. 
2021). 
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Negative Removal and Transformation Products 
Negative removal is described as a higher concentration of a compound in a WWTF’s treated 
effluent than in the influent (Golovko et al. 2021) and is a phenomenon that has been observed in 
numerous studies (Archer et al. 2015, Blair et al. 2015, Golovko et al. 2021, Hidrovo et al. 2020, 
Verlicchi et al. 2012).  A few theories exist that try to explain negative PPCP removal in 
wastewater treatment.  These include the following: (1) the activity of microorganisms breaking 
down fecal waste solids in wastewater may release PPCP particles, which assumes that the solids-
associated fraction of a compound was not detected in the influent (Blair et al. 2015, Gobel et al. 
2007), (2) there may be PPCP metabolites that remain undetected and have the ability to transform 
into their original parent compound via biotransformation (Blair et al. 2015, Jelic et al. 2011, Plosz 
et al 2010, Salgado et al. 2012, Verlicchi et al. 2012), and (3) partitioning to the aqueous phase 
may change as treatment time progresses (Golovko et al. 2021, Jelic et al. 2011, Ternes et al. 2004).  
There has also been speculation suggesting that as aqueous concentrations of PPCPs decrease 
during treatment, compounds are desorbed from sludges in the process of maintaining a “sorptive 
equilibrium” (Blair et al. 2015).  It is possible that negative removal is a result of a combination 
of the proposed theories, however Blair et al. (2015) emphasized that negative removal depends 
heavily upon the specific compound in question.   
 
In order to fully understand the life cycle of PPCPs in wastewater treatment and beyond, it is also 
important to evaluate the metabolites and transformation products of these compounds.  
Transformation products of PPCPs, which may be more or less reactive or toxic than their parent 
compounds, can arise from the incomplete removal of PPCPs (Donner et al. 2012, Dubey et al. 
2021).  This has been seen with the antiepileptic carbamazepine (Donner et al. 2012).  
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Unfortunately, many PPCP metabolites remain unknown due to a lack the of research in their 
biodegradation pathways (Pomiès et al. 2013).  The bioanalytical techniques needed to evaluate 
these unknown products also remain underdeveloped (Pomiès et al. 2013).  It is also crucial to note 
that when concentrations of PPCPs are found close to the detection limit for a specific compound, 
it introduces uncertainty regarding the accuracy of PPCP detections (Golovko et al. 2021).  In 
cases such as this, possible analytical errors may have occurred (Ort et al. 2010).  This is likely 
due to the fact that wastewater is such a complex matrix.  
 
The Microbial Communities of Wastewater Treatment 
The wastewater treatment system typically consists of two to three stages; primary treatment, 
secondary treatment, and tertiary treatment.  Primary treatment is the separation of debris and large 
solids from the wastewater.  Secondary treatment, also known as biological treatment, consists of 
nutrient removal, and oftentimes activated sludge is utilized to perform denitrification and 
phosphate removal (Saunders et al., 2016).  Wastewater also goes through some type of 
disinfection before being released into the aquatic environment and can include the utilization of 
ultraviolet rays or chlorination/dichlorination.  Tertiary treatment consists of advanced removal of 
specific constituents in wastewater and is implemented in some treatment facilities.  
 
While there are many different processes of biological treatment of wastewater, activated sludge 
is the most common engineered secondary treatment process currently being used in WWTFs 
around the world (Saunders et al. 2016, Zhang et al. 2019).  This process depends on a diversity 
of microorganisms to transform nutrients, nitrify ammonia, and remove carbon under aerobic 
conditions (Saunders et al. 2016, Seviour et al. 2010, Wu et al. 2019).  Biological treatment of 
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wastewater is also dependent upon the interaction and activity of microbial species (Fang et al. 
2018), and different types of treatment and different environmental parameters will structure 
different microbial communities (Zhang et al. 2019).  Many of the members responsible for the 
productivity of wastewater treatment, as well as the conditions influencing these microbial 
communities, are not completely defined or understood (Wu et al. 2019). 
 
Microorganisms are Integral to the Biological Treatment of Wastewater 
Biological wastewater treatment processes, specifically the activated sludge process, are known to 
contain a wide, diverse array of microorganisms.  Wu et al. (2019) suggested that the activated 
sludge microbial community was unique and showed no overlap with other habitats.  Zhang et al. 
(2012) referred to the activated sludge treatment process as a microbially diverse environment, 
with over 700 genera.  In one study, it was found that around 30 taxa comprise the global activated 
sludge core community (Wu et al. 2019).  The same study used a lognormal model to predict the 
number of species in the global activated sludge system and determined a prediction of 
1.1±0.07x109 species (Wu et al. 2019). 
 
Based upon the available literature, dominant microbial phyla have been identified in WWTFs 
around the globe, indicating a consistent prevalence of certain microbial community members in 
municipal WWTFs.  In a study by Saunders et al. 2016, it was found that the 63 core genera found 
in 13 Danish WWTFs made up 68% of the total reads corresponded to core communities found in 
other studies (Zhang et al. 2012).  In a study on microbial communities in 5 municipal WWTFs in 
China by Zhang et al. (2019), the most dominant phyla were, in order, Proteobacteria, Chloroflexi, 
Actinobacteria, Acidobacteria, Bacteroidetes, and Firmicutes. In a global analysis of activated 
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sludge systems, it was found that Proteobacteria were the most dominant community members, 
constituting 82% of the core community (Wu et al. 2019).  Yang et al (2011) also found the most 
abundant phylum to be Proteobacteria, followed by Bacteroidetes and Firmicutes.  In a review by 
Tian and Wang (2020), the most dominant phyla found in WWTFs serving municipalities around 
the world consisted of Proteobacteria, Bacteroidetes, and Chloroflexi (Figure 1.4).  Firmicutes 
and Fusobacteria were also observed to be dominant phyla in the study.  The available literature 
indicates that the dominant phyla in WWTFs include Proteobacteria, Bacteroidetes, Firmicutes, 
Chloroflexi, Actinobacteria, and Acidobacteria, alongside many other less abundant phyla. 
 
Figure 1.4: Variations in the abundant phyla in different wastewater treatment processes can be seen. The relative 
abundances of different phyla for activated sludge (CAS=conventional activated sludge) can be seen in the boxed 
section.  Proteobacteria, Bacteroidetes, Chloroflexi, and Acidobacteria appear to be the most relatively frequent phyla 
for this particular study.  Retrieved from Tian and Wang (2020). 
 
Some of the most frequently identified phyla in wastewater treatment play important roles in the 
treatment process.  The main role of Proteobacteria in the wastewater treatment process is to 
remove nitrogen, phosphorous, and organic pollutants (Zhang et al. 2012).  Bacteroidetes have 
been attributed with the ability to degrade organic matter (Thomas et al. 2011).  Firmicutes are 
frequently found in AS and are comprised of bacteria regarded to have the ability to perform 
pollutant decomposition (Zhang et al. 2019).  One type of Firmicutes, the genus Bacillus, has been 
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noted to produce enzymes that can decompose organics in sewage wastewater (Zhang et al. 2019).  
Chloroflexi are filamentous bacteria associated with sludge bulking, flocculation, and phosphorous 
removal (Mielczarek et al. 2012, Zhang et al. 2019).  Wang et al. (2012) claimed that Chloroflexi 
are omnipresent in WWTFs and may serve as important degraders of organics and nutrient 
removers.  The Saccharibacteria phylum was also omnipresent in activated sludge and is attributed 
with the removal organic matter and protein hydrolysis (Ibarbalz et al. 2013, Mielczarek et al. 
2012). 
 
The primary purpose of secondary treatment is to remove and transform carbon and nutrients, 
effectively reducing the concentration of nitrogen and phosphorous entering the natural 
environment (Saunders et al. 2016, Wu et al. 2019, Seviour et al. 2010).  Among the many 
members of the activated sludge microbial community, ammonia oxidizing and nitrite oxidizing 
bacteria (AOB and NOB, respectively) play important roles in treatment processes.  AOBs consist 
of five main genera including Nitrosospira, Nitrosomonas, Nitrosovibrio, Nitrosolobus, and 
Nitrosococcus, while NOBs consist mainly of the genera Nitrospina, Nitrobacter, and 
Nitrococccus (Zeng et al. 2015).  Two types of competing bacteria are associated with phosphorous 
removal; Glyogen accumulating organisms (GAOs) and phosphate accumulating organisms 
(PAOs).  GAOs consist of members from Competibacter, Accumulibacter, and Fluviicoccus, and 
PAOs consist of Accumulibacter and Tetrasphaera. (Fang et al. 2018). 
 
In a global survey of activated sludge systems, the top genus associated with ammonium nitrogen 
removal was Nitrospira (Wu et al. 2019).  Nitrospira has been referred to as a key nitrite oxidizing 
bacteria (NOB) (Griffin and Wells, 2017).  While it is generally accepted that Nitrospira dominate 
nitrate oxidation in activated sludge, Saunders et al. (2016) found that Nitroga nitrifiers were the 
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most abundant NOB throughout all samples included in their study.   Zhang et al. (2019) found 
low diversity of nitrifying bacteria across 5 WWTFs in China, with the two dominant nitrifiers 
being Nitrosomonas (AOB) and Nitrospira (NOB).  In a study by Griffin and Wells (2017), 
Nitrosomonas was found to be the dominant ammonia oxidizing genus of bacteria.  While the most 
abundant nitrifiers differs between WWTFs, there appears to be a core group of nitrifiers found in 
wastewater treatment processes around the world. 
 
The Parameters Influencing Microbial Assemblage 
Temperature has been regarded by many studies as a key driver of microbial growth and the 
structure of microbial communities (Griffin and Wells, 2017, Zhang et al. 2019, Wu et al., 2019).  
Therefore, it is expected that temperature is also important when evaluating microorganisms in 
activated sludge (Griffin and Wells, 2017, Seib et al. 2016).   Changes in temperature are even 
suspected to create temporal variations in how a microbial community is structured (Griffin and 
Wells, 2017).  In a study by Zhang et al. (2019), temperature was not found to be a driving factor 
behind microbial assemblage, however it is important to note that in this particular study the 
temperature between the 5 WWTFs in focus fluctuated very little.  This could mean that in order 
to see the impact temperature may have on the microbial community in WWTFs, larger 
temperature fluctuations are needed between samples. Overall, temperature has been deemed as 
extremely influential on the diversity of a microbial community, especially in WWTFs (Seib et al. 
2016, Tian and Wang 2020). 
 
In a study on the composition of the microbial communities in sludge from high-altitude WWTPs 
in Tibet, the dominant phyla, in order of dominance, included Proteobacteria, Bacteroidetes, 
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Chloroflexi, Planctomycetes, Acidobacteria, Nitrospirae, and Firmicutes (Chen et al. 2019).  It has 
been noted that WWTFs in colder, higher altitude regions of the world , known as plateau WWTFs, 
have unique microbial communities (Fang et al. 2018).  Interestingly, plateau WWTFs showed a 
lower nutrient and organic material removal compared to non-plateau WWTFs (Fang et al. 2018).  
Temperature-sensitive WWTF microorganisms cannot survive in environments below 4°C, and 
therefore correlations between altitude and temperature can be made (Fang et al. 2018).  Fang et 
al. (2018) found that WWTFs in higher altitudes with colder temperatures contained a lower 
microbial diversity attributed to temperature.  Fang et al (2018) also found that across all of the 
WWTF samples, Proteobacteria were the most abundant phylum, followed by phyla including 
Bacteroidetes, Chloroflexi, and Firmicutes.  Details on the phyla found to be most abundant in the 
WWTFs in Fang et al.’s 2018 study can be seen in Figure 1.5.  The most abundant phyla found in 
this study correlated with what has been found in the literature.  Acidobacteria, Chlorobi, 
Saccharibacteria, Actinobacteria, and Spirochaetae were also dominant phyla in the plateau 
WWTFs.  Identified phyla, in much smaller abundance, also included Planctomycetes, 
Verrucomicrobia, and Nitrospirae. 
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Figure 1.5: The microbial compositions of bacterial phyla in plateau and non-plateau (control) WWTFs.  It can be 
seen that while Proteobacteria, Bacteroidetes, and Chloroflexi dominate all WWTF samples, there are obvious 
differences between plateau and control treatment plants.  Retrieved from Fang et al. 2018.   
 
 
Although there were differences in the dominant phyla, classes, and genera of microorganisms in 
plateau and control WWTFs, 26 of the top 50 genera in all samples were the same.  These included 
members of the following genera; Flavobacterium, Anaerolineaceae_uncultured, Thauera, 
Bacteroidetes, Terrimonas, Xanthomonadaceae_uncultured, and Arcobacter. (Fang et al. 2018).  
In Fang and coauthor’s study (2018), organic removal was attributed mostly to aerobic 
heterotrophic bacteria (HET).  Overall, Fang et. al. 2018 concluded that altitude and temperature 
can impact the types of microorganisms found in WWTFs, as well functional population 
abundance.  Details regarding the relationship between temperature, altitude, and microorganisms 





Figure 1.6(A-C):  A Conical Correlation Analysis (CCA) on environmental variables and microbial community 
members.  It can be seen that temperature and altitude both influence the types of phyla, classes, and genera found in 
the observed WWTFs.  Retrieved from Fang et al. 2018. 
 
Influent composition is another factor to consider when assessing microbial communities in 
WWTFs and in activated sludge.  Griffin and Wells (2017) and Chen et al. (2017) suggested that 
the composition in the influent wastewater and differences in operating parameters between 
WWTFs influence the structure of microbial communities.  In a study by Wu et al. (2019), the 
concentration of BOD in the influent wastewater also had a significant influence on the 
composition of bacteria.  Tian and Wang (2020) also found pollutant concentration in wastewater 
influent could impact microbial communities. 
 
Dissolved oxygen was also found to be an important water parameter in wastewater treatment 
processes, especially in biological treatment (Niu et al. 2016, Seib et al. 2016).  For example, 
nitrification is driven by the dissolved oxygen concentration in the influent (Gonzales-Martinez et 
al. 2016).  In a meta-analysis on WWTFs around the world, Tian and Wang (2020) found that 
dissolved oxygen impacted the WWTF bacterial community.  While multiple studies found DO 




The operating conditions and composition of the influent wastewater may also select for the 
microorganisms present in a WWTF (Zhang et al. 2019).  In one wastewater sample, the 
distribution and structure of the microbial community in a municipal WWTF was influenced 
heavily by COD (Zhang et al. 2019).  Additionally, the results from a study on WWTFs with 
activated sludge in Denmark indicated that the microbial diversity within a single plant remained 
stable over time, leading the authors to state that variation in microorganisms found between 
WWTFs was greater than those found in a single WWTF over time (Saunders et al. 2016).  While 
pH has been speculated to influence the microbial community in a WWTF, Tian and Wang (2020) 
did not find any strong correlation between pH and microbial communities.  Griffin and Wells 
(2017) observed a seasonal change in microbial communities in the studied WWTFs, with 
diversity peaking in the fall and reaching a minimum in December and March, depending upon 
the specific facility. Spring and summer also showed a significant increase in diversity (Griffin 
and Wells, 2017).  Solids retention time, which is the length of time sludge is kept in the secondary 
treatment bioreactor, has also been observed to impact the structure of a bacterial community (Wu 
et al. 2019, Chen et al. 2017).  Sludge retention time may also cause differences in the year-to-year  
structure of microbial populations (Griffin and Wells, 2017). 
 
Wu et al. 2019 found that the structure of the activated sludge community varied across continents, 
with Asia showing the most diversity and South America showing the lowest.  It was also 
determined that process type and climate greatly impacted the structure of the microbial 
communities.  This is an area of research that should be investigated further.  Covariation should 
also be considered when evaluating microbial community structure, as WWTFs operate with many 
different variables involved their treatment processes (Griffin and Wells, 2017).  It is possible that 
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multiple factors (e.g. temperature and pH combined) have a great impact on the type of 
microorganisms present in a WWTF. 
 
Species and Enzymes Linked to PPCP Biodegradation 
An evaluation of enzymes associated with the degradation of pollutants, including PPCPs, can give 
insight into the metabolic potential of a microbial community.  While research regarding the field 
of PPCP degradation is ongoing, some enzymes have been identified that aid in the breaking down 
of PPCPs.  The most frequently identified classes in the literature, which can be seen in Table 1.1 
below, include Monooxygenase, Laccase, Tyrosinase, and Peroxidase enzymes.  Monooxygenases 
have bene regarded to catalyze degradation reactions of organic contaminants (Tran et al. 2013), 
including sulfonamide antibiotics (Deng et al. 2018).  More specifically, Flavin Monooxygenases 
have been identified to aid in the degradation of tetracyclines and sulfonamides by Oberoi et al. 
(2019) and Reis et al. (2018), respectively.  Laccase enzymes have also been described as some of 
the most researched micropollutant-degrading enzymes (Varga et al. 2019).  Another group of 
enzymes, Tyrosinases, have been generally described to degrade pharmaceuticals (Becker et al. 
2016, Varga et al. 2019).  Additionally, the breakdown of Ciprofloxacin, as well other organic 
pollutants, have been ascribed to lignin and manganese peroxidases (Chowdhardy et al. 2018, 
Inoue et al. 2010, Mao et al. 2010, Oberoi et al. 2019, Torres et al. 2003).  A detailed description 






Table 1.1: The major enzyme classes described to catalyze PPCP degradation reactions.  Included in this table are the 
class and specific type of enzyme, as well as the specific types of reactions they catalyze and their corresponding 
sources. 




Emerging Organic Contaminants 
Sulfonamides 
• Tetracyclines; Sulfonamides 
Tran et al. 2013,  Deng et al. 2018 
• Oberoi et al. 2019, Reis et al. 
2018 
Laccases Pharmaceuticals; Sulfonamides; 
Tetracyclines; Ciprofloxacin 
Varga et al. 2019; Yang et al 2017; 
Oberoi et al. 2019 
Tyrosinases Pharmaceuticals Becker at al. 2016, Varga et al. 2019 
Peroxidases 




• Ciprofloxacin; Organic 
Pollutants 
• Xenobiotics; Organic 
Pollutants; Ciprofloxacin 
Varga et al. 2019 
• Oberoi et al. 2019, Mao et al. 
2010; Torres et al. 2003; Wen et 
al. 2010 
• Chowdhardy et al. 2018, Inoue 
et al. 2010; Oberoi et al. 2019 
 
It is also worth noting that there are microbial groups observed to degrade and even utilize PPCPs.  
Table A1.4, included in Appendix A, provides a description of the microbial groups and species 
that have been identified with the ability to biodegrade and mineralize sulfonamide antibiotics.  
Interestingly, many of the organisms described to degrade sulfonamides fall within the 
Pseudomonas species.  Many studies also attributed Pseudomonas species with the degradation of 
sulfamethoxazole, a type of sulfonamide antibiotic.  It is important to note that while an enzyme 
or species may be associated with the degradation or break down of a pollutant, further analysis is 
needed to determine whether a specific biodegradation pathway is active within a sample. 
 
The importance of Understanding the Microbial Aspects of Wastewater Treatment 
It is crucial to understand the types of organisms that are found in wastewater treatment, as well 
as their metabolic functions to take advantage of the benefits microorganisms provide in 
wastewater treatment (Saunders et al. 2016).  By observing the dynamics of WWTF microbial 
populations, researchers can better understand the metabolic functions that these communities 
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serve (Saunders et al. 2016).  It is also necessary to validate if the organisms found in WWTFs are 
active (Saunders et al. 2016).  By understanding the microorganisms and community structures 
involved with the treatment of wastewater, engineers and scientists can improve the biological 
treatment system to be the most efficient and effective (Wu et al. 2019). 
 
Regarding the activated sludge treatment process, it is important to understand the ecology of AS 
processes in order of optimize wastewater treatment systems (McIlroy et al. 2015).  By 
understanding the microbial communities found in AS and the dynamics surrounding their 
formation, engineers can optimize WWTF process and design, therefore improving the wastewater 
treatment process (Nielsen et al. 2012).  It is possible that organisms that are found in low 
abundance contribute to micropollutant removal, having an advantage through a specialized niche 
(Saunders et al. 2016).  The microorganisms and the functions they serve ultimately determine the 
performance of wastewater treatment (Fang et al. 2018). 
 
There are many organisms that are not found abundantly in AS microbial communities, and it is 
possible that they have a significant role in the function of the AS ecosystem (Saunders et al. 2016).  
Saunders et al. (2016) indicated that less abundant microorganisms may take on the role of a seed 
bank for the AS community, providing stability during fluctuations of environmental conditions, 
and perhaps even play an important role in the degradation of micropollutants.  Microbial diversity 
has been linked with positive pollutant removal, and an understanding of the factors influencing 
how a microbial community is structured allows for the optimization of biological treatment 
processes, increased biodiversity, and improvement of nutrient and pollutant removal (Wu et al. 
2019, Zhang et al. 2016).  Ma et al. (2013) indicated that treatment systems are more stable with 
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higher microbial diversity.  Understanding the ecological, physiological, and genetic traits of 
members of the WWTF community can help engineers select microorganisms based on the 
functions desired for treatment (Wu et al. 2019).  For these reasons, more research dedicated 
towards understanding these complex communities and their metabolic potential is needed. 
Following Chapters 
The purpose of this chapter was to provide an overview of current research within the field of 
pharmaceuticals and personal care products in wastewater treatment, as well as provide the 
framework for original research regarding the biotransformation and fate of these contaminants.  
My thesis consists of three separate projects, each with PPCPs as the main theme tying the projects 
together.  Chapter 2 will include details for the sampling and detection of PPCPs in surface water, 
while Chapter 3 will describe my research on the partitioning of PPCPs in wastewater treatment.  
Chapter 4 will cover the last project of my thesis research, which investigates the microbial 
community members of wastewater treatment and possible PPCP degradation enzymes.  Each 
chapter will provide the methodology, results, and discussions for my original thesis research.  The 
final section of the thesis, Chapter 5, will discuss the direction for future work and next steps within 
my areas of research. 
Main Research Objectives 
Motivation 
Secondary wastewater treatment has been observed to perform removal of PPCPs despite 
wastewater treatment processes not being designed for the removal of these contaminants.  
However, further questions remain regarding the mechanisms of compound removal, as well as 
the life cycle and fate of PPCPs.  Prior research has shown that removal efficiency of PPCPs can 
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vary greatly, even for compounds within the same pharmaceutical class.  The main mechanisms 
of removal include; (1) biodegradation, (2) sorption to sludges, and (3) volatilization.  Due to the 
structure and nature of PPCPs, volatilization is not considered a significant mechanism of removal, 
leaving biodegradation and sorption to sludge as the focus for my research. 
 
The goal of this thesis is to expand the following fields of knowledge within environmental 
engineering: (A) monitoring of PPCPs in regional surface water, (B) the sequestration of PPCPs 
into sludges during wastewater treatment (2) the microbial communities attributed with PPCP 
biodegradation, (3) the influence of PPCPs on the wastewater microbiome, (4) and the enzymes 
associated with PPCP biodegradation in regional WWTFs.  Research has identified microbial taxa 
present in WWTFs that have the ability to degrade PPCPs, however questions still remain 
regarding the specific species and enzymes involved, as well as the conditions that influence 
microbial assemblage.  Prior studies, including one by former M.S. student Alexandria Hidrovo, 
detected PPCPs in both the aqueous and sludge phases of wastewater treatment.  The information 
presented in this literature review indicates difficulty with predicting PPCP behavior during 
treatment, including their sorption to sludge. 
 
Research Aims 
My research aims to: (1) sample for a large list of pharmaceutical compounds and personal care 
products, including a large subset of antibiotics, in regional surface water locations (2) analyze 
16S rRNA sequences received from prior research (Hidrovo et al. 2020) to evaluate how microbial 
communities change based on treatment type, (3) perform metagenomic sequencing on regional 
WWTF samples to evaluate the microbial taxa present and identify biodegradation pathways, and 
(4) evaluate trends regarding PPCP fractionation to sludges in secondary wastewater treatment. 
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Research Hypotheses 
In Chapter 2, I will evaluate pharmaceuticals and personal care products in regional surface water 
locations. 
Hypotheses:  
(1) With an expanded list of 46 PPCPs included in our analysis, a total of 10 different PPCPs 
will be detected in Great Bay Estuary surface water locations, including at least 5 
antibiotics, in July 2020. 
(2) Sulfamethoxazole will be detected in all surface water locations in July 2020. 
(3) A least one of the two personal care products included in our analysis will be detected 
across all surface water locations in July 2020. 
Rationale (a): Multiple WWTFs have effluent outfalls in rivers that lead to the Great Bay Estuary, 
indicating that an evaluation of the compounds present in the surface waters of this region may 
give insight into which compounds are not being fully removed from wastewater streams, and 
subsequently entering the natural environment.  Surface water sampling in the Great Bay Estuary 
of New Hampshire in the summer of 2020 will help identify contaminants of emerging concern 
that are present in the region.  Prior research has indicated the presence of PPCPs, including 
antibiotics, in the Great Bay Estuary.  If a larger range of antibiotics are included in sample 
screening, then more compounds within this class may be detected.   
Rational (b): A prior study by Hidrovo et al. (2020) detected nine different PPCPs in the Great 
Bay Estuary, including three antibiotics. Many PPCPs that are present in surface water samples 
may not be detected simply because the screening is not broad enough to account for them.  
Literature indicates that the continued monitoring of PPCPs in surface water is needed to fully 
understand the extent of their presence in aquatic matrices.  Therefore, we are including an 
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expanded list of PPCPs, with a larger number of antibiotics included compared to 2019, to evaluate 
the presence of these compounds in the context of a larger PPCP analysis.  
 
Chapter 3 will consist of a fractionation analysis of PPCP sequestration into sludge during 
wastewater treatment. 
Hypotheses: 
(1) Pharmaceuticals will dominate aqueous samples, and personal care products will dominate 
sludge samples (both in abundance by weight). 
(2) All five antibiotics included in screening will be detected within the secondary effluent 
and/or sludge samples of each WWTF. 
(3) The KD values found in existing literature will be predictive for the behavior of personal 
care products in wastewater treatment, while the KD values associated with pharmaceuticals 
will not serve as good indicators of their sorption behavior. 
 
Rationale: Certain PPCPs in WWTFs may fractionate to sludge more readily than others, which 
could be explained by their assigned KD values.  Prior research has shown that the physiochemical 
properties of a PPCP, as well as the operational conditions of a WWTF, may predict whether it 
will partition to sludges or exist in the aqueous phase.  By combining the results of sludge analysis 
and PPCP detections, we may be able to better predict the behavior of these compounds during 
treatment processes.  Evaluating the compounds that are partitioning to sludges during wastewater 
treatment produces implications far beyond wastewater treatment.  Despite there being a high 
inconsistency in the KD values reported for PPCPs, due to lack of research and variability by 
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matrix, many people working within the field of contaminants of emerging concern agree that KD 
is a useful tool for predicting the fate of these contaminants.  
 
In chapter 4, I will evaluate the microbial communities in regional wastewater treatment facilities 
and their ability to degrade PPCPs. 
Hypotheses: 
(1) Bacterial will comprise >90% of microbial samples, eukaryotes will comprise <10% of 
samples, and viruses will comprise <1% of samples analyzed using Illumina Sequencing.  
For 16s rRNA Sequencing, bacteria will encompass >90% of microbial samples, and 
archaea will encompass <10% of samples. 
(2) Temperature will be the most influential factor driving microbial assemblage in the 
WWTFs sampled, while pH will be the second most influential factor. 
(3) Sludge samples will have a higher microbial diversity and species richness than aqueous 
samples. 
(4) Samples with a higher number and concentration of antibiotics detected will exhibit lower 
microbial diversity. 
(5) Micropollutant metabolism will comprise <10% of cellular activities within each WWTF. 
(6) At least one enzyme class associated with PPCP biodegradation will be observed for each 
WWTF, via the metagenomic sequencing results. 
 
Rationale: Based on current literature and previous research, the wastewater microbial community 
is mostly made up of bacteria, with some eukaryotes, viruses and archaea present.  A comparison 
of the metagenomics and 16S rRNA results will instill confidence in our data and provide a basis 
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for subsequent analyses.  In accordance with prior research in the field, it is hypothesized that 
temperature will be the most influential condition shaping the microbial communities of 
wastewater treatment.  Different temperatures may favor the growth of certain microbial taxa, 
influencing abundance and members that can be detected via sequencing.  Additionally, multiple 
studies have shown that pH is a highly influential factor not only in pollutant removal, but also for 
microbial community structure, and may be influenced by the season.  Therefore, it is expected 
that pH will have a strong influence on the current study’s microbial communities as well. 
 
The influence of PPCPs on microbial growth and assemblage is still an evolving field of research, 
however studies have indicated that PPCPs have some sort of influence on the microbial 
communities in wastewater treatment.  It is hypothesized that samples with higher concentrations 
of PPCPs, specifically pharmaceuticals, may exhibit lower microbial diversity.  This is based upon 
the knowledge that many pharmaceuticals, particularly antibiotics, are designed to inhibit 
microbial growth.  Prior research in the field (Hidrovo et al. 2020) has observed removal of some 
PPCP compounds, including acetaminophen, caffeine, atorvastatin, and cotinine.  This indicates 
that there is a possibility that biodegradation could be occurring for some of the PPCPs included 









Presence and Concentration of an Extended Antibiotic List in the 
Great Bay Estuary, New Hampshire 
Introduction and Background 
Pharmaceuticals and personal care products (PPCPs) are biologically active compounds that pose 
a potential risk to ecosystem and human health (Gaffney et al. 2017, Baran et al. 2011, Liu et al. 
2018) due to their incomplete removal in wastewater treatment (Blair et al. 2015, Gago-Ferrero et 
al.  2017, Golovko et al. 2014, Jelic et al. 2011, Sörengård et al. 2019), increasing human 
consumption (Jelic et al. 2011), and frequent detection in wastewater streams and natural 
ecosystems around the world (Dubey et al. 2021, Halling-Sorensen et al. 1998, Kummerer et al. 
2009).  Pharmaceuticals include antibiotics, anticonvulsants, and other types of prescribed 
medications.  Personal care products consist of non-medical compounds used for a variety of 
applications, including as flame retardants and insect repellents.  While previous studies have 
observed varied rates of removal for some PPCPs (Archer et al. 2017, Golovko et al. 2021), 
conventional wastewater treatment was not designed to handle these complex compounds.  
Subsequently, PPCPs are released into and detected in surface water environments varying in 
concentrations from ng/L to mg/L (Archer et al. 2017, Golovko et al. 2021, Sörengård et al. 2019).  
Research in the field has identified a need for continued monitoring of these compounds in surface 
water (Bilal et al. 2020, Brausch and Rand 2011, Hidrovo et al. 2020) to fully understand the 
present of these contaminants, in addition to identifying which compounds should be prioritized 
for legislative action. 
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Research completed by former master’s student Alexandria Hidrovo (Hidrovo et al. 2020) focused 
on identifying PPCPs in regional WWTFs and local surface water locations in the Great Bay 
Estuary, NH in order to determine compounds that posed the greatest risk the natural environment.  
Her study focused on 21 PPCPs, including the following pharmaceutical compounds; an analgesic, 
antibiotics, anticonvulsants, sedatives, a B-blocker, a narcotic, a statin, a selective serotonin 
reuptake inhibitor, and sedatives.  Personal care products included in her study included flame 
retardants, an insect repellent, a stimulant, and a tobacco metabolite.  Hidrovo et al. (2020) found 
that incomplete removal was occurring for some of the PPCPs in the four WWTFs sampled, 
including meprobamate, phenytoin, TCPP, carbamazepine, TDCPP, and fluoxetine.  A full list of 
the compounds and their corresponding detections can be seen in the supplemental information 
(Table B1.1).  Fourteen of the twenty-one compounds tested were detected in surface water, with 
concentrations ranging from 1.1 to 150 ng/L.  Five surface water locations were chosen (Figure 
2.1) in and around the Great Bay Estuary (GBE) in New Hampshire.  Hilton Park was sampled in 
both March and July of 2019 the Portsmouth Mill Pond, Adams Point, the middle of the GBE, and 
Squamscott river locations were sampled in August of the same year.  Compounds detected in 
surface water included five antibiotics, an anticonvulsant, a B-blocker, and six personal care 
products.  Hidrovo et al. (2020) concluded that incomplete removal of PPCPs in wastewater 
treatment led to their presence and detection in surface water environments and recommended 
further monitoring of these compounds in surface water ecosystems. 
 
In a continuation of the research completed by Hidrovo et al. (2020), we chose to focus on 
continued monitoring of a larger list of PPCPs in the Great Bay Estuary, NH.  The Great Bay 
Estuary (GBE) was chosen based on previous research in the field (Hidrovo et al. 2020) in addition 
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to the fact that multiple WWTFs have effluent outfalls in rivers leading into the GBE.  This makes 
the GBE a location that could be used to indicate the PPCPs that exit WWTFs due to incomplete 
removal in treatment, subsequently entering the natural environment.  The goal of this chapter was 
to evaluate whether or not the same compounds would be detected in July 2020 as were in July 
2019, and to determine which compounds were present given an extended list of screened PPCPs.  
It was predicted that a total of 10 different PPCPs will be detected in the selected surface water 
locations, including at least 5 antibiotics, in July of 2020.  We also expected the antibiotic 
sulfamethoxazole to be detected in all surface water locations.  In addition, it was predicted that at 
least two personal care products would be detected across all surface water locations.  Predictions 
were based on previous research conducted in the Great Bay Estuary (Hidrovo et al. 2020).  The 
main objective of this study was to identify which PPCPs are present in regional surface water 
locations, and to compare these results with the findings of 2019 surface water sampling completed 
by Hidrovo et al. (2020). 
 
Methodology 
Five surface water locations were sampled in July 2020 (Figure 2.1), including Hilton Park, Adams 
Point, the middle of the Great Bay Estuary, where the Squamscott River enters the Great Bay, and 
the North Mill Pond.  A MasterFlex E/S Portable Sampler (model 07516-12) was used to collect 
samples approximately one meter below the water’s surface.  Two sterile, 500-mL HDPE bottles 
were used to collect samples at each location; one for PPCP analysis (conducted by a commercial 
lab) and one for water quality analysis conducted at the University of New Hampshire, Gregg Hall 
Environmental Engineering Microbiology Laboratory. Bottles and caps were rinsed three times 
with sample water before sample was collected. All surface water samples were taken at low tide. 
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Field parameters, including temperature, pH, conductivity, salinity, and dissolved oxygen 
(Appendix B, Table B1.5), were taken at each location using a Thermo Scientific Orion Star A329 
Portable pH/ISE/Conductivity/RDO/DO Meter calibrated before use.  Equipment was rinsed with 
sterilized MilliQ water between sample collection, and all samples were kept on ice.  
 
Surface water samples were shipped overnight to SGS AXYS Analytical Services Ltd. (Sidney, 
British Columbia, Canada) for PPCP analysis via Acid Extraction according to Method MLA-075 
REV 07 VER 08 (US EPA, 2007).  A list of the 46 compounds included in our analysis, including 
their classifications, is included in Table 2.1.  Water quality analysis performed at UNH included 
ammonia nitrogen using Hach Method 10205 TNT Plus 831, chemical oxygen demand using Hach 
Method 8000 TNT plus 821/82, and orthophosphate using Hach Method 8048 (Appendix B, Table 
B1.6). 
 
Figure 2.1: Image of Great Bay Estuary located in southeast New Hampshire.  Boxed numbers indicate surface water 
sampling locations, while colored circles indicate WWTF effluent outfalls.  Size and color of circles indicate the flow, 
in million gallons per day, for each facility.  Image source Hidrovo et al. (2020). 
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Results received from SGS AXYS were imported into R Studio (Version 1.3.1073).  Relative 
abundance of PPCPs and relative percent abundance of PPCPs were calculated from total detected 
concentrations in ng/L, and data was visualized through bar plots and scatterplots with Base R. 
 
Results 
In July of 2020, 46 compounds (including 33 antibiotics) were included in a follow up surface 
water sampling event conducted at approximately the same locations as those included by Hidrovo 
et al. (2020).  Nine PPCPs were detected by Hidrovo et al. (2020) across surface water locations 
during March 2019, while twelve were detected across surface water locations in July 2019 (Table 
2.1). Sulfamethoxazole, carbamazepine, atenolol, TCPP, TDCPP, caffeine, and DEET were 
detected in both March and July of 2019.  However, only five of 46 compounds were detected 
across surface locations in 2020 (Table 2.2), with the remaining 41 below analytical detection 
limits (Table 2.3). The concentrations of these five compounds in 2020 ranged from 0.65 to 11.6 
ng/L.  The highest concentration detected was for the Squamscott River location, with 
carbamazepine detected at 8.48 ng/L.  The highest number of PPCPs detected was also seen for 
Squamscott River, with a total of 5 different compounds which can be seen in Figure 2.2. 
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Figure 2.2: A map of the 
surface water locations 
sampled in 2019 and 2020.  
Detection comparisons 
between the two years can 
be seen, with 
sulfamethoxazole and 
carbamazepine being the 
only two compounds that 
were detected in both 
sampling years. 
 
PPCPs measured in July 2020 included three antibiotics (ciprofloxacin, clarithromycin, and 
sulfamethoxazole), one anti-convulsant (carbamazepine), one calcium channel blocker 
(Diltiazem), and one antihistamine (Diphenhydramine).  As can be seen in Figure 2.2, no PPCPs 
were detected at the North Mill Pond and Adam’s Point locations.  Interestingly, all five 
compounds detected in 2020 were detected in the Squamscott River location, while only two were 
detected in the middle of GBE, and one in Hilton Park.  Sulfamethoxazole and diphenhydramine 
were detected at 0.985 and 0.653 ng/L in the GBE location.  The one PPCP detected at Hilton Park 
was Sulfamethoxazole (1.25 ng/L).  The most frequently detected compound was the antibiotic 
sulfamethoxazole, which was detected in its highest concentration at the Squamscott River site, at 
11 ng/L.  The second-highest concentration at this location was 8.48 ng/L for carbamazepine.  The 
only detections for clarithromycin (1.6 ng/L) and diltiazem (1.04) ng/L were also found in the 
Squamscott River location.   
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A comparison of the 2019 and 2020 surface water sampling events can be seen in Figure 2.2.  Two 
compounds, sulfamethoxazole and carbamazepine, were the only PPCPs detected both years.  In 
2019, sulfamethoxazole was detected at 5.8 and 3.6 ng/L in March and July respectively while this 
same compound was detected at 1.1 ng/L in July of 2020.  Similarly, carbamazepine was detected 
in concentrations of 2.8 and 4.5 ng/L in March and July of 2019 while in July 2020 it was detected 
at 2.1 ng/L. 
Table 2.2: Table of the analytes detected in SW samples for March and July 2019, and July 2020.  White indicates no 
detection, blue indicates detection, and gray indicates that a specific analyte was not analyzed.   
 
 

















































































Table 2.3: Analytes measured in the July 2020 surface water sampling analysis that were below analytical detection 





PPCPs are frequently detected in natural environments around the world and are still being 
detected in surface water locations in New Hampshire, as observed in this study.  PPCPs were 
detected in the GBE both in 2019 and in 2020.  While the overall number of PPCPs detected in 
surface water sampling in 2020 was lower than those detected in 2019, sulfamethoxazole and 
carbamazepine were detected in both sampling events. Overall, a smaller number of PPCPs were 
detected in 2020, despite the expansion of compounds included in our analysis, from 21 
compounds in 2019 to 46 in 2020.  A total of only five compounds were detected across all surface 























































channel blocker.  The antibiotics clarithromycin and sulfamethoxazole were detected in 
concentrations of 1.6 ng/L and 0.985–11.6 ng/L, respectively.  The anticonvulsant carbamazepine 
was detected at one location, the Squamscott River site, at a concentration of 8.48 ng/L.  
Diphenhydramine, an antihistamine, was detected in the GBE (0.653 ng/L) and Squamscott River 
(1.47 ng/L) locations.  The calcium channel blocker diltiazem was detected at 1.03 ng/L in the 
Squamscott River location as well. 
 
It has been speculated that the COVID-19 pandemic and subsequent lockdown may have impacted 
the number and concentration of PPCPs detected in 2020 surface water sampling.  With less people 
interacting with each other, non-COVID-19 viral and bacterial infections may have been reduced, 
resulting in a lower prescription of antibiotics.  In study by Rawson et al. (2020) on the impact of 
the COVID-19 pandemic on antimicrobial resistance, the potential impacts of COVID-19 
healthcare precautions were discussed.  Through social distancing between individuals in a 
community, there was a decrease in infections, and thus reductions in the prescription of 
antimicrobial medications (Rawson et al. 2020).  Additionally, Oster et al. (2021) stated that the 
prevention of non-COVID-19 respiratory pathogens may have been a consequence of the increased 
measures taken in healthcare to prevent the rise of COVID-19.  It was suggested that social 
distancing, school closures, and the utilization of face masks in the fight against COVID-19 
infections may have also restrained the frequency of other respiratory pathogens (Oster et at. 2021).  
Additionally, Nieuwlaat et al. (2021) also indicated that the interventions put in place to prevent 
COVID-19 from spreading may have decreased other infections from spreading from human to 
human, and subsequently decreased the use of medications prescribed.  A study completed by Wee 
et al. (2021) on a heath care campus in Singapore observed a decrease in hospital-acquired-
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infections, including respiratory viral infections and MRSA, during the COVID-19 pandemic in 
2020.  The authors attributed this decrease to the increased COVID-19 precautions taken on the 
health care campus (Wee et al. 2021). 
 
In addition to current research in the field regarding antibiotic usage during the COVID-19 
pandemic, the United States Center for Disease Control (CDC) also identified changes in antibiotic 
prescription during the year of 2020 (Center for Disease Control 2021).  The CDC preliminarily 
concluded that prescription of antibiotics in outpatient and nursing home settings decreased in the 
months of April and May 2020, when compared to these two months in 2019 (Center for Disease 
Control 2021, Srinivasan 2020).  The CDC stated that more patients chose not to visit healthcare 
centers or hospitals for needs that were not urgent during this time, and also recognized that social 
distancing practices and the closure of schools may have also influenced a decrease in infections, 
and subsequently a decrease in antibiotic prescription (Center for Disease Control 2021).  
However, it is important to note that the CDC did observe an increase in the usage of azithromycin 
and ceftriaxone, antibiotics used to treat community-acquired pneumonia, during April and May 
of 2020 (Srinivasan 2020).  Based upon the current literature and findings from the CDC, it is 
possible that the COVID-19 lockdown impacted PPCP detections in our 2020 sampling event.  
With less people interacting with each other, non-COVID-19 infection rates may have fallen in 
New Hampshire, resulting in a lower prescription of antibiotics, lower consumption, and lower 
discharge of these compounds from WWTFs.  However, it is important to note these changes in 
antibiotic prescription may not have been significant enough to impact our PPCP detections in 
surface water.  Additionally, New Hampshire experienced a severe drought in the summer of 2020, 
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which may have also impacted the transport and concentration ranges of detected PPCPs in the 
Great Bay Estuary. 
 
While 46 PPCPs were included in our analysis in July of 2020, only five compounds were detected 
across the surface water locations. The anticonvulsant carbamazepine, the calcium channel blocker 
diltiazem, and antihistamine diphenhydramine were detected.  Carbamazepine is used to treat 
conditions such as epilepsy and trigeminal neuralgia, while diltiazem is used to treat angina 
pectoris and hypertension (PubChem 2021).  Out of the 33 antibiotics included in our screening, 
clarithromycin and sulfamethoxazole were the only two detected.  As is indicated by their 
antibiotic classification, these two compounds can be used against an array of bacterial infections 
in humans.  Clarithromycin is a semisynthetic macrolide that has been used to treat patients 
suffering from a wide array of ailments, including; urinary tract infections, skin infections, lower 
respiratory tract infections, cholera, and bacterial meningitis (National Institute of Health Office 
of Aids Research 2021, PubChem 2021). Many of these infections could continue despite COVID-
19 lockdown procedures. Similarly, sulfamethoxazole is sulfonamide antibiotic that is frequently 
prescribed alongside the antibiotic trimethoprim (, PubChem 2021).  Patients are given these 
antibiotic(s) if they are suffering from urinary tract infections, gastrointestinal tract infections, 
respiratory infections, diarrhea, and some cases of chronic bronchitis (National Institute of Health 
Office of Aids Research 2021, PubChem 2021). The detection of only two antibiotics in 2020 
indicates that 31 antibiotics were not detected.  Considering the current research related to 
antibiotic usage during the COVID-19 pandemic, it is plausible that the COVID-19 lockdown may 
have influenced the number of antibiotics that were or were not detected in the Great Bay Estuary 
in July of 2020.  However, more data are needed to instill confidence in this notion. 
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A broader list of screening did not necessarily mean more PPCPs were detected.  In addition, it is 
important to note that there could also be compounds that were not included in our screening that 
may be present in the surface water locations sampled.  Additionally, some of the compounds that 
were included in our study could have been present below the detection limit of Method MLA-
075 REV 07 VER 08, which was used for PPCP analysis.  Boxall (2004) stated that wide ranges 
of pharmaceutical compounds, including antibiotics, have been found in the environment in low 
concentrations.  This preludes to the possibility that there may be many different types of 
compounds in the environment that remain undetected via current analytical technology detection 
limits.  This is alarming, considering that many studies indicate that the chronic toxicity of PPCPs 
on non-target organisms can occur at low concentrations, even those below the therapeutic doses 
for humans (Brausch and Rand 2011, Daughton and Ternes 1999, Galus et al. 2013,).  A study by 
Brain et al. (2004) that focused on the toxicity of 25 pharmaceuticals, including 22 antibiotics, on 
the aquatic plant Lemna gibba.  The authors determined that tetracycline, sulfonamide, and 
fluoroquinolone antibiotics exhibited the greatest toxicity on L. gibba.  Sulfamethoxazole was 
found the be the most toxic of the sulfonamide antibiotic class, causing growth inhibition, chlorotic 
injury, chlorosis, necropsy, and root detachment at varying concentrations (Brain et al. 2004).  
Other toxic sulfonamides included sulfamethazine and sulfadimethoxine (Brain et al. 2004).  
Fluoroquinolone antibiotics, including ciprofloxacin, were observed to cause new plant fronds to 
bleach, as well as growth inhibition depending on the test concentration (Brain et al. 2004).  
Additionally, Brandhof and Montforts (2010) observed lack of hatching of Zebra fish (Danio 
rerio) embryos, in addition to growth delay, when exposed to carbamazepine.  Effects observed at 
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varying concentrations of carbamazepine also included tail deformation and heart abnormalities 
(Brandhof and Montforts, 2010). 
 
The chronic exposure of aquatic organisms and plants to PPCPs remains a field of research that is 
developing, which heightens the concern for the presence of even low concentrations of these 
compounds in the environment, in addition to the impact that mixtures of different PPCPs may 
have on an aquatic ecosystem (Baran et al. 2011, Brausch and Rand, 2011, Daughton and Ternes, 
1999, Galus et al. 2013).  We suggest continued monitoring of PPCPs in the Great Bay Estuary, 
especially for sulfamethoxazole and carbamazepine, as these compounds were detected in both 
2019 and 2020.  We also recommend studies that investigate toxicity of mixtures of PPCPs, as this 
is more realistic to what is occurring in the natural environment (Boxall, 2004).  While the presence 
of all PPCPs in the natural environment should be addressed, a prioritization of specific 
compounds or classes of PPCPs can help aid in the creation of legislation regarding regulations 












Partitioning of 21 Pharmaceuticals and Personal Care Products into 
Aqueous and Solid Phases During Wastewater Treatment 
 
Abstract 
Pharmaceuticals and personal care products (PPCPs) are contaminants of emerging concern that 
have been detected in municipal wastewater treatment systems across the globe.  In the current 
study, grab samples were taken from the treatment processes of four wastewater treatment facilities 
(WWTFs) in seacoast New Hampshire.  Secondary influent, secondary effluent, chlorinated 
effluent, dechlorinated effluent, and sludges were tested for 21 PPCPs, including 15 
pharmaceuticals and six personal care products.  A range of 19-20 PPCPs were detected in 
secondary effluent samples, and a range of 5-11 PPCPs were detected in sludges.  Personal care 
products were detected in higher parts per billion (ppb) concentrations on average than 
pharmaceuticals across all wastewater samples.  Antibiotics and fire retardants dominated sludge 
samples in percent abundance by weight, indicating that these compounds classes are sorbing to 
sludges more readily than others.  The usage of treated biosolids for land applications highlights 
the importance of evaluating the behavior of PPCPS during wastewater treatment, and the presence 
of these contaminants in sludges. 
 
Introduction 
The removal of PPCPs in wastewater treatment has been observed to vary greatly (Jelic et al. 2011, 
Miege 2009, Oulton 2010, Verlicchi 2012), and compounds that belong to the same 
pharmaceutical class may not necessarily exhibit similar sorption behavior.  This is because 
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compounds within the same class can vary greatly in their physicochemical properties (Hörsing 
2011).  The main routes of PPCP removal include biodegradation via microorganisms (Jelic et al. 
2011, Joss et al. 2006, Ternes et al 2004), sorption to sludges and solids (Jelic et al, 2011, Joss et 
al. 2006, Ternes et al. 2006), chemical transformation (Jelic et al. 2011), and volatilization (Joss 
et al. 2006).  This current chapter focusses on the sorption of PPCPs to sludges during wastewater 
treatment, as contaminants of emerging concern have been found to sorb to sludges in previous 
studies (Camacho-Munoz et al. 2012, Golovko et al. 2021).  Although sludges are processed prior 
to use in different applications, the contaminants remaining in land-applied sludges may runoff 
into the surrounding aquatic ecosystems (Golovko et al. 2021) in addition to possible uptake by 
plants (Al-Farsi et al. 2017, Carter et al. 2014, Dodgen et al. 2013, and Shenker et al. 2011). 
Sludges that are not applied for land use may be incinerated or disposed of through landfilling, 
which can percolate into groundwater sources (Golovko et al. 2021).  Therefore, determining 
partitioning behavior of contaminants of emerging concern can help aid in the prediction of PPCP 
behavior and give insight into their ultimate fate. 
 
A study by former master’s student Alexandria Hidrovo (Hidrovo et al. 2020) focused on the 
analysis of 21 PPCPs in four wastewater treatment facilities (WWTFs) in seacoast New 
Hampshire.  Her study found a total of 12 PPCPs in the sludge samples of the four WWTFs.  
Fluoxetine, ciprofloxacin, TDCPP, TCPP, and DEET were detected in the sludge samples from 
each WWTF.  Hidrovo et al. (2020) concluded that fewer PPCPs were detected in the solid phase 
compared to the liquid phase at each facility, indicating that the majority of the PPCPs included in 
the study remained in the aqueous phase.  However, the study also found ciprofloxacin to be the 
most concentrated compound within the sludge samples, in addition high concentrations of TCPP 
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and TDCPP.  The remaining WWTF PPCP detection data from Hidrovo et al.’s (2020) research 
were used in our current study to further investigate the behavior of PPCPs during wastewater 
treatment. 
 
The main objective of this chapter was to evaluate the behavior of PPCPs in wastewater treatment, 
specifically secondary (or biological) treatment.  Previous studies have discussed PPCP fate and 
predicting compound behavior during secondary treatment (Gurung et al. 2019; Hörsing et al., 
2011; Sertillanges et al. 2020; Shah et al. 2020) however more research is needed to fully 
understand the fate of PPCPs during different treatment processes.  We expected to observe the 
majority of pharmaceutical detections in the aqueous phase, and the majority of the personal care 
products to be detected in the sludges.  Also expected was the detection of all five antibiotics 
within the secondary effluent and/or sludge samples of each WWTF included our analysis.  We 
also aimed to investigate whether or not partition coefficients (KD) found in the existing literature 
for the target PPCPs will have any prediction in compound behavior during wastewater treatment.  
Our study was also geared towards observing trends in PPCP detections along the treatment train, 
especially for antibiotics.  
 
Methodology 
Discrete grab samples were taken from four regional wastewater treatment facilities (WWTFs) by 
Hidrovo et al. (2020) in five locations along the treatment process (Figure 3.1).  Aqueous phase 
samples were collected into amber glass bottles containing ascorbic acid and sodium azide as 
preservatives, and sludge samples were collected into glass jars without preservatives.  All samples 
were kept on ice during sampling and shipped overnight to Weck Laboratories, Inc. (Hacienda 
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Heights, CA), after which PPCP analysis was carried out according to EPA Method 1694 (U.S. 
EPA, 2007), with the use of mass spectrometry (MS), liquid chromatography (LC) and 
electrospray ionization (ESI).  Water quality measurements were also taken for secondary influent 
and effluent with a calibrated Thermo Scientific Orion Star A329 Portable pH/ISE/Conductivity/ 
RDO/DO Meter, and included pH, conductivity, dissolved oxygen, redox potential, temperature, 
chemical oxygen demand, ammonia content, non-purgeable organic carbon, and total dissolved 
nitrogen (Table 3.1). 
 
Figure 3.1: Sampling locations within each WWTF included secondary influent (1), secondary effluent (2), 
chlorination (3), dechlorination (4), and sludge (5).  Image adapted from Hidrovo et al. (2020). 
 
 
Table 3.1:The water quality parameters for secondary influent and secondary effluent samples at each WWTF.  
WWTF is indicated by the number in front of the sample ID.  DO=dissolved oxygen, REDOX=oxidation reduction 
potential, Temp=temperature, COD=chemical oxygen demand, NPOC=non-purgeable organic carbon, TDN=total 




Detected concentrations for PPCPs were received from Weck Laboratories, Inc in ng/L.  Data were 
imported into R Studio (Version 1.3.1073) and MATLAB (R2019a), and average cpncentrations, 
relative and percent abundances of PPCPs were calculated according to molecular mass.  Results 
were visualized using bar plots in R Studio and MATLAB, which compared the concentrations of 
PPCPS at different treatment stages in parts per billion concentrations (ppb) and in percent 
Sample ID pH Conductivity DO REDOX Temp COD Ammonia NPOC TDN
1-Sin 7.7 885.1 4.4 -34.4 20.6 288.5 44.5 42.4 44
1-Sout 7 731.1 0.3 -4 22.5 16.4 1 5.3 12.4
2-Sin 7.3 839.2 4.2 -22.5 22.8 88.2 30.7 26.9 31
2-Sout 6.5 667.2 1 26.8 23.9 24.3 1 7.3 3.1
3-Sin 7.5 877.6 1.6 -31.3 21.3 182.4 38.6 40.3 37.8
3-Sout 6.7 755.8 0.9 14.5 22.2 36.6 1 8.8 3.7
4-Sin 7.3 1124 2.1 -22.1 23 314.3 51.5 54.4 46.1
4-Sout 6.6 816.7 1.9 18.7 23.5 19.8 1 6.4 3.4
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abundance by weight.  The secondary aqueous and sludge samples were also visualized for 
comparison using R Studio. 
 
Results 
A comparison on the percent abundance of pharmaceuticals and personal care products across 
treatment phases can be seen in Figure 3.2, below.  Percent abundances for each phase were found 
by first calculating the average atomic weight of each compound across the WWTFs.  The percent 
abundance by weight was then calculated by dividing the compound average atomic weight by the 
summed atomic weight for all PPCPs.  The results presented in Figure 3.2 indicate that the 
dominant major classes of PPCPS remained generally the same along the treatment process.  
Pharmaceuticals dominated both the aqueous and sludge samples, comprising about 53.7% of 
secondary influent, 64.6% of secondary effluent, 50.4% of chlorination, 55.4% of dechlorination, 
and 68.9% of sludge detections by weight.  Personal care products were found to be most abundant 




Figure 3.2: The percent abundance of pharmaceuticals and personal care products by weight, according to treatment 
stage.  Abundances presented in this figure were determined by taking the average concentration across all four 
WWTFs.  The average, maximum, and minimum values are indicated by the standard deviation bars. 
 
An analysis on the ppb of PPCPs was also performed (Figure 3.3).  Parts per billion concentrations 
of pharmaceuticals and personal care products were calculated by taking the average of each 
compound concentration in ng/L for aqueous concentrations and converting to ppb.  For sludge 
samples, concentrations in ng/kg were also converted to ppb.  The ppb concentrations were then 
visualized with bar plots using MATLAB.  As seen in Figure 3.3, personal care products dominated 
ppb detections for all treatment stages.  The aqueous sample with the highest average ppb 
concentration of PPCPs was secondary influent (1.4 ppb), while the sludge was found to contain 
the highest concentration at about 6.6 ppb total.   
 
The significant decrease in total PPCPs in ppb from secondary influent (~1.4 ppb) to secondary 
effluent (~0.1 ppb) indicates that there was a decrease in PPCP concentrations in the aqueous phase 
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during secondary treatment processes.  We observed about a 92% decrease in the average ppb 
concentration for both pharmaceuticals and personal care products from secondary influent to 
secondary effluent.  An additional decrease of about 78% and 44% was seen for pharmaceuticals 
and personal care products from chlorination, respectively. While the concentration of personal 
care products dropped about 4.5% during dechlorination, there was about a 14% increase in the 
concentration of pharmaceuticals during this treatment stage.  Sludge contained about 64 times 
higher PPCPs ppb than secondary effluent.  
 
Figure 3.3: The average parts per billion concentrations of pharmaceuticals and personal care products by weight in 
parts per billion (ppb) for aqueous and sludge phases.  The inner y-axis correlates to the aqueous phase samples; 
secondary influent, secondary effluent, chlorination, and dechlorination. The outer y-axis correlates to sludges. 
 
To find out which compounds made up the PPCPs detected in aqueous and sludge samples, the 
average percent abundance of chemical classes by weight was calculated.  This was done by 
calculating the molecular weight (mol/L aqueous, mol/kg sludge) for each pharmaceutical 
compound, and averaging these across the four WWTFs for compound classes. We observed that 
the relative abundances of PPCP compound classes changed with the different treatment stages 
(Figure 3.4).  Analgesics dominated secondary influent, comprising about 50% of detections in 
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this phase, but these compounds are removed on an undetectable level after secondary treatment.  
Anticonvulsants and flame retardants dominated chlorination (24.5% and 37%) and dechlorination 
samples (25.7% and 35.7%) while antibiotics dominated sludges and secondary effluent, making 
up about 41% and 61% of the compounds detected for each phase, respectively. The highest 
relative abundance of any one PPCP class by weight was observed in the sludge sample, indicating 










Figure 3.4: The average percent abundance by weight of PPCP classes in wastewater samples by weight for each 
treatment process, representing the average all 4 WWTFs sampled. 
 
To evaluate the specific compounds that were being detected in the sludge samples of each WWTF, 
the percent abundance by weight of each PPCP compound in mol/kg was calculated using 
molecular mass.  Figure 3.5 presents these results and reveals ciprofloxacin, TCPP, and TDCPP 
as prevalent compounds across all sludge samples.  The sludge of WWTF 2 was dominated by 
TCPP (28.4%), followed by TDCPP (20.1%) and caffeine (18.7%).  Ciprofloxacin was most the 
most abundant compound in WWTF 2, comprising about 83.9%, followed by TCPP (9.1%) and 
fluoxetine (3.3%).  The most abundant compound by weight for WWTF 3 was also ciprofloxacin 
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(64.2%), after which the following two most abundant compounds were TCPP (10.7%) and 
caffeine (5.9%).  The most abundant compounds by weight for WWTF 4 followed a similar trend 
as those seen for WWTF 1, with the top three most abundant compounds being TCPP (42.5%), 
Ciprofloxacin (26.8%), and TDCPP (14.9 %).  Five compounds, including ciprofloxacin, TCPP, 




Figure 3.5: The percent abundance of specific compounds detected in sludges by weight for each WWTF. 
Most of the antibiotics we analyzed in this study were detected at least once in the secondary 
treatment samples of each WWTF, except amoxicillin and azithromycin (Table 3.2).  These two 
antibiotics were not detected in any of the secondary treatment samples or sludge of WWTFs 1 
and 2.  Interestingly, azithromycin was detected in the secondary effluent of WWTF 3, however 
not in the secondary influent.  Ciprofloxacin was the only compound that was detected in the 





Table 3.2: Detection table of antibiotics in secondary treatment aqueous samples and sludge.  Secondary influent 
samples are signified by “Sin” and the secondary effluent samples are indicated by “Sout.”  An orange box indicates 




A review of the current literature surrounding the sorption coefficient (KD) values of PPCPs was 
completed (Table 3.03.  A KD value was found for all 21 compounds analyzed in this study, with 
the exception of two flame retardants (TCPP and TDCPP), and one tobacco metabolite (cotinine).  
Table 3.3 presents the KD values found in the literature, the ranges of these values for each 
compound, and the media that was used to experimentally determine the coefficients.  Based on 
the information summarized in this table, it was expected that the compounds with the highest KD 
value ranges (e.g. azithromycin, ciprofloxacin, trimethoprim, phenytoin, primidone, diazepam, 
fluoxetine, and DEET) would be found in the highest relative abundances in the sludges.  This 
trend was observed for ciprofloxacin and TCPP in the sludge samples but was not always the case 
for trimethoprim, phenytoin, primidone, diazepam, and fluoxetine, DEET.  Some compounds with 
a reportedly higher KD range were not observed in high abundances in sludges compared to those 
with a lower reported KD range.  To demonstrate this, consider the antibiotics trimethoprim and 
ciprofloxacin.  Trimethoprim (KD = 1.4 – 4.8) constituted less than 1% abundance by weight in 
each sludge samples, except for WWTF 1, in which this compound constituted about 2.6%.  
Azithromycin (KD = 2.4 – 7.1) remained below detection limit in the sludges of WWTFs 1, 2, and 
4, and constituted less than 1% of abundance by weight in the sludge.  Additionally, a comparison 
of the antibiotics ciprofloxacin and trimethoprim may support the prediction of compounds using 
their assigned KD values.  Ciprofloxacin was detected in high concentrations in the sludges than 








WWTF 3WWTF 2 WWTF 4WWTF 1
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trimethoprim and was found in the literate to have a larger range of KD values.  Ciprofloxacin (KD 
= 3.6 – 7.3) was detected at a concentration of 300 ng/L in secondary effluent and 580 ng/L in 
sludges, while trimethoprim (KD = 1.4 – 4.8) was detected at 270 ng/L in secondary effluent and 
7.6 ng/L in sludges of the same facility. 
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Table 3.3: Compiled KD values found from the literature for the PPCP analyzed this thesis.
 
Analyte Range Source Media
Acetaminophen 1.6232 Kreuzig et al. 2003 test sludge
Amoxicillin 0.0253 Jones et al. 2002 sludge
Giebułtowicz et al. 2020 sludge
Sidhu et al. 2019 biosolids (referring to sludge)
Joss et al. 2006 activated sludge
Gobel et al. 2005 activated sludge
Abegglen et al. 2009 activated sludge
Giebułtowic et al. 2020 sludge
Golet et al. 2003 activated sludge
Sidhu et al. 2019 biosolids (referring to sludge)
Hörsing et al. 2011 primary sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Hörsing et al. 2011 secondary sludge, short sludge age
Giebułtowic et al. 2020 sludge
Huang et al. 2019 activated sludge
Fernandez-Fontaina et al. 2013 activated sludge
Abegglen et al. 2009 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Radjenovic et al. 2009 activated sludge
Joss et al. 2006 activated sludge
Gobel et al. 2005 activated sludge
Hyland et al. 2012 activated sludge
Hörsing et al. 2011 primary sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Hörsing et al. 2011 secondary sludge, short sludge age
Giebułtowic et al. 2020 sludge
Fernandez-Fontaina et al. 2013 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Hyland et al. 2012 activated sludge
Gobel et al. 2005 activated sludge
Xue et al. 2010 activated sludge
Radjenovic et al. 2009 activated sludge
Abegglen et al. 2009 activated sludge
Jones et al. 2002 sludge
Huang et al. 2019 activated sludge
Fernandez-Fontaina et al. 2013 activated sludge
Abegglen et al. 2009 activated sludge
Ternes et al. 2004 activated sludge
Wick et al. 2009 activated sludge
Urase and Kikuta 2005 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Hyland et al. 2012 activated sludge
Radjenovic et al. 2009 activated sludge
Hörsing et al. 2011 primary sludge
Stevens-Garmon et al. 2011 activated sludge
Hyland et al. 2012 activated sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Stevens-Garmon et al. 2011 activated sludge
Abegglen et al. 2009 activated sludge
Hörsing et al. 2011 secondary sludge, short sludge age
Jones et al. 2002 sludge
Wick et al. 2009 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Radjenovic et al. 2009 activated sludge
Methadone 1.8808 Wick et al. 2009 activated sludge
Hörsing et al. 2011 primary sludge
Ternes et al. 2004 activated sludge
Wick et al. 2009 activated sludge
Hyland et al. 2012 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Stevens-Garmon et al. 2011 activated sludge
Hörsing et al. 2011 secondary sludge, short sludge age
Stevens-Garmon et al. 2011 activated sludge
Muñoz et al. 2009 activated sludge
Hyland et al. 2012 activated sludge
Atorvastatin 1.9685-2.2967 Stevens-Garmon et al. 2011 activated sludge
TCEP 1.8129-2.3636 Stevens-Garmon et al. 2011 activated sludge
TCPP
TDCPP
Hyland et al. 2012 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Xue et al. 2010 activated sludge
Stevens-Garmon et al. 2011 activated sludge
















Compounds with larger experimentally determined KD values were expected to sorb to sludges 
more readily than those with lower KD values.  However, the large ranges of KD values reported 
in literature make prediction difficult, and a deeper understanding of the behavior of these 
compounds during different treatment process, and in the face of different operational parameters, 
is needed to gain confidence in predicting the fate of contaminants. Unfortunately, due to the lack 
of prior research and information regarding the KD values of PPCPs, a partition coefficient could 
not be found for TCPP or TDCPP, compounds that were both found in high abundances in sludges 
in this study.  The wide range in KD values for PPCPs found in literature can be partially attributed 
to the matrix used to determine experimentally these coefficients (Pomiès et al. 2013), which 
introduces some error and uncertainty into our interpretation of the results presented in this chapter.  
The results of our partitioning study in combination with experimentally calculated KD values from 
the literature indicate that there is a range of behavior that can be expected for these compounds 
during wastewater treatment. 
 
Factors that may influence PPCP partitioning behavior during wastewater treatment, as well as 
experimental KD values, are continuously being explored by researchers.  Previous studies have 
found that the pH (Sertillanges et al. 2020), temperature (Hörsing et al. 2011, Sertillanges et al. 
2020; Shah et al. 2020), and solids retention time (Gurung et al. 2019) of a WWTFs unit processes 
can influence the distribution and fate of PPCPs during wastewater treatment.  Hörsing et al. (2011) 
found pH to directly impact the sorption of eight pharmaceutical compounds to secondary sludge, 
including fluoxetine, chloropramine, fuloxetine, levomeprobamazine, nefadezone, loperamide, 
sertraline, and chloprothixene.  Carbamazepine and naproxen were also observed to display a 
higher sorption to sludge at lower pH levels (Hörsing et al. 2011).  Hörsing et al. (2011) also found 
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that an increase in pH from 6 to 8 decreased the percent fractionation of certain pharmaceuticals 
to the aqueous phase, including the selective serotonin reuptake inhibitor fluoxetine.  
Carbamazepine, which was detected in two sludge samples in this study, has been described to 
have a higher affinity for sludge at low pH levels (Hörsing et al. 2011).  All WWTFs in our study 
exhibited a drop in pH from secondary influent to secondary effluent, with the greatest drops in 
pH observed for WWTTs 2 and 4.  Wastewater treatment facility 1 had the highest measured pH 
for secondary effluent (pH = 7), while facility 2 had the lowest for secondary effluent (pH = 6.5).  
A correlation analysis evaluating the secondary effluent concentration of carbamazepine versus 
secondary effluent pH for our study indicated there was no significant relationship between 
carbamazepine detections and pH in the selected WWTFs secondary effluent samples (Figure 
C1.1).  Interestingly, a correlation analysis comparing the concentration of fluoxetine and pH 
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Figure 3.6: A correlation analysis of secondary effluent pH levels versus secondary effluent concentration of 
fluoxetine (ng/L) for the four sampled WWTFs.   
Temperature, a less-investigated factor, is also suggested to impact sorption behavior of PPCPs 
(Sertillanges et al. 2020, Shah et al. 2020).  Additionally, Hidrovo et al. (2020) found that higher 
solid retention times in wastewater treatment correlated positively with higher removal of PPCPs 
from the aqueous phase.  Additionally, current literature has also highlighted the importance of 
hydrophilicity and hydrophobicity of compounds in influencing their behavior (Gurung et al. 2019, 
Shah et al. 2020). The differences in pH, SRT and temperature, as well as basin operation and 
secondary treatment process type, are suspected to influence the average percent abundances of 
PPCPs in liquid versus sludge for the present study.  However, it is important to note that the 
results of this study cannot definitively support if these specific parameters influenced the 
compounds that were detected within in the WWTFs included in our study.  This is an area that 
should be further explored in future research. 
 
Pharmaceuticals were observed to dominate all aqueous samples and sludge in our study, 
sometimes with only a slight majority over personal care products.  Pharmaceuticals comprised an 
average of 53% of secondary influent, 65% of secondary effluent, about 50.4% of chlorination, 
and 55% of dechlorination samples, averaged across the four WWTFs.  This can perhaps be 
explained by the nature and usage of pharmaceuticals, and how these compounds were designed 
to act when prescribed in humans and animals, in addition to their biodegradability.  Additionally, 
pharmaceuticals encompassed about 69% of sludges, compared to only 31% of personal care 
products. When evaluating PPCP detections in ppb, personal care products were observed to have 
higher abundances by weight than pharmaceuticals for all samples, as can be seen in Figure 3.3.  
It was also expected that all five antibiotics would be detected within at least one of the secondary 
treatment samples of each WWTF.  Each antibiotic was detected at least once across all secondary 
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treatment samples, as seen in Table 3.2.  Each antibiotic was also detected in the secondary 
treatment samples for each WWTF, except for amoxicillin, which was not detected in the 
secondary influent, secondary effluent, or sludge sample for WWTF 1.  These results highlight the 
fact that these compounds are not only present in wastewater entering municipal WWTFs for 
treatment, but also in the treated effluent and the sludges. 
 
The detection of compounds in secondary effluent samples but not in secondary influent samples, 
an example of which can be seen in Table 3.2, is a phenomenon that can be described as negative 
removal.  Negative removal is when a compound is detected in a higher concentration in the 
effluent leaving treatment than in the untreated influent entering treatment.  Current research 
indicates that negative removal may be attributed to microbial activity releasing PPCP particles in 
fecal waste, which assumes that PPCPs remain undetected when entering WWTFs in this form 
(Blair et al. 2015, Gobel et al. 2007).    It is important to note that matrix issues are very likely the 
cause of negative removal seen in our study, due to dilution or matrix interference of dirty samples 
in which compounds may not be as well detected as well.  Other explanations include PPCP 
metabolites transforming into their original parent compound through biotransformation (Blair et 
al. 2015, Jelic et al. 2011, Plosz et al. 2010, Salgado et al. 2012, Verlicchi et al. 2012), and even 
the partitioning of compounds to the aqueous phase as treatment time progresses (Golovko et al. 
2021, Jelic et al. 2011, Ternes et al. 2004).  While the mechanisms behind negative removal are 
not fully understood, it is important to note that negative removal is highly dependent upon the 
compound in question (Blair et al. 2015).  
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The utilization of processed, treated sludges from WWTFs for land use is very common throughout 
the world (Dubey et al. 2021) and has been described as a prominent route for PPCPs to enter the 
environment (Ternes et al. 2004).  PPCP compounds can also enter the natural environment 
through the reclamation of treated wastewater for irrigation purposes (Al-Farsi et al. 2017).  Many 
species of plants have been observed to have the ability to uptake PPCPs present in the terrestrial 
environment (Al-Farsi et al. 2017, Dodgen et al. 2013, Carter et al. 2014, and Shenker et al. 2011).  
PPCPs can subsequently accumulate in plant tissues, possibly posing a hazard to humans and 
animals if ingested (Al-Farsi et al. 2017).  This is alarming considering that there is currently no 
federal or state legislature limiting the concentrations of PPCPs in sludges or wastewater effluent.  
In order to protect the environment, human health, and to minimize the risks PPCPs pose, research 
needs to be dedicated towards monitoring PPCPs and evaluating their behavior in treatment 
processes, in addition to effective legislative measures that can mitigate the impact of contaminants 
of emerging concern. 
 
The current study evaluated the partitioning of PPCPs between aqueous and sludge phases in four 
seacoast New Hampshire WWTFs. Antibiotics and fire retardants made up very high percent 
abundances by weight in the sludge samples of the WWTFs. Based on the result of this study, we 
recommend further research into the KD values in different wastewater matrices of the 21 PPCPs 
included in our analysis, in addition to research that investigates the behavior of these compounds 
during different wastewater treatment processes and operational parameters.  We also recommend 
the prioritization of monitoring for fire retardants and antibiotics in sludge treatment.  Continued 
research on PPCP partitioning during treatment processes can help researchers understand the 
behavior and fate of PPCPs during wastewater treatment. 
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CHAPTER 4 
The Microbial Communities and PPCP-Degrading Potential of 
Wastewater Metagenomes 
Abstract 
The biological treatment of wastewater has long been referred to as the heart of secondary 
wastewater treatment.  This process relies on the ability of microbial communities for carbon and 
suspended solids removal, in addition to the reduction of nitrogen and phosphorous.  There are 
multiple methods to perform secondary treatment, including activated sludge, the BardenPho 
system and oxidation ditches.  While these processes have been credited with removing some 
legacy and emerging pollutants in addition to nutrient removal, they were not designed for the 
degradation of complex compounds of emerging concern.  Among these compounds, 
pharmaceuticals and personal care products (PPCPs) are of concern due to their detection in 
aquatic matrices around the world and their wide consumption in humans and animals.  
Additionally, these compounds have been speculated to influence the microorganisms present in 
wastewater microbial communities.  The aim of this study was to investigate the microbial 
communities present in four regional wastewater treatment facilities (WWTFs), and to evaluate 
the diversity of different secondary treatment methods, as well as the influence water quality 
parameters and pollutants have on microbial taxa. Microbial community composition of 
wastewater samples targeting the 16S rRNA gene as well as metagenomic sequencing of a subset 
of wastewater samples was performed, and bacteria were found to be the dominant domain in each 
facility. Diversity indices, including Shannon Diversity and species richness, indicated that sludges 
contained some of the highest diversity indices found across all samples.  NMDS analyses 
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indicated that sulfamethoxazole, TDCPP, and DEET were the most influential PPCPs on microbial 
phyla, while five of the nine water quality parameters were found to be statistically significant in 
their influence. The study also identified five enzymes of interest detected in in the WWTFs 
sampled that have been associated catalyzing PPCP-degrading reactions.  This study aimed to shed 
light on the diversity of the microorganisms and degradation enzymes present within wastewater 
treatment, as well the factors influencing wastewater microbial communities. 
 
Introduction 
Contaminants of emerging concern, including pharmaceuticals and personal care products 
(PPCPs), have been described as substances that enter the natural environment via incomplete 
removal in wastewater treatment facilities (WWTFs) (Blair et al. 2015, Gago-Ferrero et al.  2017, 
Golovko et al. 2014, Jelic et al. 2011, Sörengård et al. 2019).  Pharmaceuticals describe any 
compound that is prescribed for medical use, including antibiotics, anticonvulsants, and pain 
relievers, and personal care products include insect repellents, fire retardants, and stimulants.  
While WWTFs can degrade PPCPs to some extent, they were originally designed for the removal 
of nutrients, including nitrogen and phosphorous.  Scientists are concerned with PPCPs not only 
because these compounds are frequently detected in surface water around the globe, but because 
small concentrations of these compounds can have significant negative impacts on non-target 
organisms (Meyer et al. 2019, Petrie et al. 2015, Sörengård et al. 2019).  This is especially true for 
antibiotic compounds that enter the natural environment.  Antibiotics, including sulfamethoxazole, 
a common antibiotic prescribed in humans, are not completely metabolized by the body, and can 
be excreted as a sulphuric or glucuronic acid conjugate, or as a metabolite (Kovalakova et al. 
2020).  Additionally, conventional wastewater treatment does not efficiently remove antibiotics 
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that are received into WWTFs for municipal wastewater treatment (Bilal et al. 2020, Kovalakova 
et al. 2020).  These compounds subsequently exit WWTF in effluent and are received into the 
natural environment.  Not only is research regarding the overall impacts of PPCPs in the natural 
environment lacking, but also the chronic toxicity of these pollutants on non-target organisms 
remains an ongoing field of research. 
 
The degradation and removal of PPCPs that has been observed in wastewater treatment can be 
attributed to volatilization, sorption to sludge, and biodegradation via microorganisms (Pomiès et 
al. 2013).  While volatilization and sorption to sludges are methods that should be explored further, 
this chapter focused on the microbial communities that degrade these compounds.  The secondary 
wastewater treatment processes typically employ microbial communities for suspended and 
dissolved carbon, nitrogen, and phosphorus removal (Saunders et al. 2016), as well as the removal 
of legacy and emerging pollutants.  Wu et al. (2019) suggested that activate sludge wastewater 
treatment consisted of a microbial community unlike any other and predicted the presence of a 
billion species (1.1±0.07x109).  While many studies have been oriented on describing the microbial 
members of different treatment processes, the extent of the diversity and function of these 
communities, particularly related to PPCP removal, is not fully understood. 
 
Based upon the available literature, dominant microbial phyla may occur across WWTFs 
worldwide.  In a study by Saunders et al. 2016, it was found that the 63 core genera found in 13 
Danish WWTFs make up 68% of the total reads corresponded to core communities found in other 
studies (Zhang et al. 2012).  In a study on microbial communities in 5 municipal WWTFs in China 
by Zhang et al. (2019), the most dominant phyla were, in order, Proteobacteria, Chloroflexi, 
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Actinobacteria, Acidobacteria, Bacteroidetes, and Firmicutes. In a global analysis of activated 
sludge systems, it was found that Proteobacteria was the most dominant community phylum, 
constituting 82% of the core community (Wu et al. 2019).  Yang et al (2011) also found the most 
abundant phylum to be Proteobacteria, followed by Bacteroidetes and firmicutes.  In a review by 
Tian and Wang (2020), the most dominant phyla found in WWTFs serving municipalities around 
the world consisted of Proteobacteria, Bacteroidetes, and Chloroflexi.  Firmicutes and 
Fusobacteria were also observed to be dominant phyla in the study.  The available literature 
indicates that the dominant phyla in WWTFs include Proteobacteria, Bacteroidetes, Firmicutes, 
Chloroflexi, Actinobacteria, and Acidobacteria, alongside many other less abundant phyla. 
 
There are many factors described to influence the microbial communities that exist in wastewater 
treatment, including temperature (Seib et al. 2016,Tian and Wang 2020, Wu et al. 2019), pH (Tian 
and Wang 2020), influent wastewater composition (Griffin and Wells, 2017, Chen et al. 2017, 
Zhang et al. 2019), dissolved oxygen (Niu et al. 2016, Seib et al. 2016), and WWTF operational 
parameters (Cydzik et al. 2016, Isazadeh et al. 2016, Tian and Wang 2020, Tiwari et al. 2017, 
Zhang et al. 2019) such as solids and hydraulic retention time.  Pharmaceuticals and personal care 
products may also influence microbial communities in wastewater treatment (Tian and Wang 
2020).  A study by Onesios-Barry et al. (2014) explored the influence of these pollutants on 
wastewater microorganisms by evaluating microbial protein concentration.  This study applied a 
mixture of PPCPs to columns inoculated with WWTF effluent and evaluated microbial community 
composition.  The authors found that initial PPCP concentration influenced the extent of PPCP 
biological removal.  A study by Tian and Wang (2020) also stated that pollutant concentrations 
may influence wastewater microbial communities.  Additionally, a study by Zhang et al. (2020) 
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evaluated the influence of the PPCP sulfadiazine, ibuprofen and carbamazepine on moving bed 
biofilm reactors.  The authors found that concentrations of PPCPs less than 2mg/L stimulated 
microbial growth and caused an increase in diversity.  However, when PPCPs were present at 
5mg/L a decrease in microbial diversity was observed.  Zhang et al. (2020) concluded that the 
presence of PPCPs produced a different type of microbial community structure within the moving 
bed biofilm reactors evaluated.  
 
Metagenomic sequencing is a novel technique that can be used to gain insight into the microbial 
communities of wastewater treatment.  This method can be used to describe not only the bacterial 
and archaeal members of a microbial community found via 16S rRNA sequencing, but also the 
eukaryotes, fungi, and viruses present.  Metagenomic sequencing using Illumina sequencing has 
been used in previous studies to evaluate the microbial communities of wastewater treatment (Guo 
et al. 2017, Tian and Wang 2020), the genes present in wastewater microbiomes (Guo et al. 2017b, 
Tang et al. 2016), and metabolic pathways (Guo et al. 2017a).  Metagenomics sequencing has 
allowed researchers to evaluate the function and structure of a microbial community and has been 
described to overcome the biases of PCR and culture-dependent methods (Fang et al. 2013).  This 
novel method is also able to provide a new perspective on microbial community composition as 
well as the abundance and diversity of biodegradation genes, especially for organisms that are not 
easily cultured (Fang et al. 2013).  A study by Fang et al. (2013) found a strong presence of 
biodegradation genes in samples from two WWTFs in China, including pmo and p450 genes.  This 
study also utilized the MG-RAST platform to identify 87 bacterial genera that were described with 
the potential to degrade pollutants, including microorganisms belonging to Proteobacteria, 
Actinobacteria, and Bacteroidetes phyla. 
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As is discussed above, metagenomic sequencing can provide information regarding the function 
of microorganisms present in a sample, as well as metabolic potential of the community.  The use 
of metagenomic sequencing can also be helpful in determining if PPCP biodegradation pathways 
and enzymes are present in a given sample.  While enzymatic presence is not indicative of an 
active biodegradation pathway, it can describe whether or not the microbial community members 
have the potential to degrade specific pollutants.  For these reasons, metagenomics has been 
deemed a useful tool for modeling pollutant biodegradation pathways in addition to describing the 
complex and diverse microbiome of wastewater treatment. 
 
Project Background and Motivation 
Four regional wastewater treatment facilities located in seacoast New Hampshire were sampled in 
July of 2019.  Grab samples were taken from secondary treatment influent, within secondary 
treatment processes, and from secondary effluent.  Sludge samples from the secondary treatment 
phase of each facility were also taken, as was de-watered sludge which collects from primary and 
secondary phases.  A total of 25 samples from the four facilities were included in the analysis of 
microbial community members. One composite sample from each facility consisting of 
subsamples collected from secondary treatment phases was used for metagenomic sequencing (4 
total). Sequencing of the 16S rRNA gene was conducted to gain insight into the bacterial and 
archaeal community members present in the samples while metagenomic sequencing was 
completed to understand the metabolic potential of the microbial communities in present in 
secondary treatment. The secondary wastewater treatment processes for each facility can be seen 
below, in Figure 4.1.  WWTFs 2, 3, and 4 implement a Bardenpho system for secondary treatment 




Figure 4.1: The Bardenpho method (A) and the oxidation ditch process (B) were implemented by the WWTFs 
sampled in the current study. 
 
There were three main goals for the analysis of the wastewater microbial communities in this 
study; (1) to gain insight into the diversity of the microorganisms in secondary wastewater 
treatment, (2) to evaluate the influence of operational parameters and water quality, and how these 
conditions may shape wastewater microbial communities, and (3) to observe any trends for 
microbial taxa and metabolic potential associated with measured PPCPs. The following 
predictions were formed based on current literature to address our hypotheses; (1) Prokaryotes 
(bacteria and archaea) will comprise the majority (>90%) of microbial taxa in these samples, with 
eukaryotes (<10%) and viruses (<1%) comprising a minority.  For 16S rRNA Sequencing, bacteria 
will encompass >90% of microbial samples, and archaea will encompass <10% of samples, (2) 
temperature will be the most influential factor driving microbial assemblage in the WWTFs 
sampled, while pH will be the second most influential factor, (3) sludge samples will have a higher 
microbial diversity and species richness than aqueous samples, (4) samples with a higher number 
of antibiotics detected will exhibit lower microbial diversity, (5) micropollutant/xenobiotic 
metabolism will comprise <10% of cellular activities within each WWTF, and (6) at least one 
enzyme associated with PPCP biodegradation will be present in metagenomic data for each 




Four wastewater treatment facilities (WWTFs) located in the seacoast region of New Hampshire 
were chosen for the study, sampled in July 2019, and stored in sterile sample containers at -80C 
before processing.  Three of the WWTFs implement Bardenpho design while the fourth 
implements an oxidation ditch design.  Grab samples were retrieved from the secondary treatment 
basins for each WWTF, with samples taken from each individual zone.  Samples were shipped 
overnight to Weck Laboratories, Inc. in California, where sample extraction followed by PPCP 
analysis via liquid chromatography followed by mass spectrometry via electrospray ionization was 
implemented according to EPA method 1694 (U.S. EPA, 2007). 
 
DNA Extraction and Sequencing 
Microbial total nucleic acids were extracted from samples using a Qiagen DNEasy Powersoil 
extraction kit.  This extraction kit has been used in previous research to evaluate the microbial 
community members of wastewater, including bacteria, eukaryotes, and viruses (Albastaki et al. 
2021, Petrini et al. 2020, Redhead et al. 2020, Ren et al. 2021, Trebuch et al. 2021).  A silica 
membrane was used to capture, rinse, and elute genomic DNA, which was then stored at -80 ºC 
until samples were sequenced.  Microbial community analysis was conducted using universal 
primers obtained from the Earth Microbiome Project (Earth Microbiome Project, 2021) that 
targeted the V4 region of the 16S rRNA gene in accordance with the protocol set out by Caporaso 
et al. (2012).  Sequencing was performed using an Illumina HiSeq 2500 with Rapid Run 
chemistries at the Hubbard Center for Genome Studies at the University of New Hampshire 
(Durham, NH).  Gel electrophoresis was utilized to check fragment length, including positive and 
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negative controls.  Amplicons were then sent for analysis using 16S rRNA sequencing at the 
Hubbard Center for Genome Studies at the University of New Hampshire.   
 
Remaining DNA samples were pooled according to WWTF and sent for metagenomic sequencing.  
Shotgun metagenomics via Illumina sequencing using Illumina HiSeq 2500 was performed at the 
University of New Hampshire’s Hubbard Center for Genome Studies.  Both ends of the DNA 
strands were sequenced, known as paired-end sequencing (Illumina, 2017).  Paired-end sequencing 
produces forward and reverse strands, which can be paired for more accurate alignment (Illumina, 
2017).  This method also produces twice the number of reads compared to single-red sequencing, 
resulting in higher quality reads (Illumina, 2017).  During Illumina Sequencing, single-stranded 
DNA is hybridized (Voelkerding et al. 2009).  This is followed by bridge amplification, after which 
clusters are denatured and cleaved (Voelkerding et al. 2009).  The next step adds polymerase to 
initiate sequencing, which grows chains via nucleotide addition (Voelkerding et al. 2009).  The 
fluorescence is then recorded, and the next synthesis cycle is started (Voelkerding et al. 2009).  
The number of cycles included in sequencing determines the length of the read (Voelkerding et al. 
2009).  The maximum read length for HiSeq 2500 is 250bp (Illumina, 2021). 
 
Sequence Processing 
Data from 16S rRNA sequencing was processed using QIIME2 (Bolyen et al. 2018).  Sequences 
were demultiplexed, trimmed for quality, and then denoised using DADA2, and an amplicon 
sequence variant (ASV) table was subsequently created (Callahan et al. 2016).  Metagenomic 
databases, including KBase and MG-RAST, were utilized for data analysis of the sequences 
received from Illumina sequencing.  Workflow within KBase was completed according to Chivian 
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et al. (2020).  Raw sequences were imported to KBase as fastaq reads and were paired according 
to the forward and reverse file pathways.  The interleaved setting was indicated, as well as the type 
of sequencing.  The quality of the files was assessed using FastQC v0.11.5.  Read quality was also 
read after each subsequent step in the sequence processing.  Reads were then trimmed using 
Trimmomatic v0.36, after which assembly was carried out via metaSPAdes v3.13.0.  Trimming 
was done on the reads once more before apps to evaluate microbial taxonomy were utilized.  
Taxonomy was evaluated using the KBase applications GOTTCHA2 and Kaiju.  Paired, trimmed 
reads were run through Kaiju with RefSeq Genomes as the reference database.  The GOTTCHA2 
viral and bacterial database were used as the reference database for the GOTTCHA2 application. 
 
Raw Illumina sequences were also imported into MG-RAST as unpaired forward and reverse 
sequences.  The following sequence processing described was done automatically within MG-
RAST as described in the MG-RAST user manual (MG-RAST, 2019); The reads were first 
preprocessed using SolexaQA, which trims low-quality regions of the sequence data.  The dataset 
was then dereplicated using k-mer to perform rapid identification of 20-character identical 
sequences.  Duplicate Read Inferred Sequencing Error Estimation (DRISEE) was also 
implemented to analyze the Artificial Duplicate Reads (ARDs), which determined the variation 
between sequences.  Bowtie was then implemented to screen and remove reads that are associated 
with genomes of non-microbial organisms, such as humans, mice, and cows.  For feature 
identification within MG-RAST, the following pipeline was used; protein coding gene calling, 
rRNA detection, protein filtering, AA clustering at the 90% identity level, and protein 
identification, rRNA similarities, profile generation, and database loading.  Microbial phylogeny 
was evaluated using RefSeq databases, and the enzymes present within each wastewater facility 
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sample were determined using KO databases within MG-RAST, using representative hits with 
60% identification and an e-value of 6.   
 
Dominant Microbial Domains 
To evaluate the abundance of bacteria and archaea, amplicon sequence variant (ASV) data based 
on 16S rRNA gene sequences were imported into MATLAB (R2019a), and percent abundances 
were calculated from the number of total reads per domain. The results were then visualized using 
pie charts in MATLAB to produce a percent abundance representation of the domains present in 
each WWTF (Figure 2).  A table showing the number of ‘hits’ for each WWTF by domain was 
also made to evaluate the domains that were too small in percent abundance to be seen clearly in 
the pie charts.   
 
Microbial Diversity 
The sequencing results were also imported into R Studio (Version 1.3.1073), and the following 
packages were used in the microbial analyses implemented in this study; stats, ade4, vegan, gclus, 
FD, BiocManager, ggplot2, MASS, labdsv, cluster, and indispecies.  To evaluate the microbial 
diversity of the wastewater samples, multiple diversity indices were calculated using R Studio.  
These indices included the Inverse Simpson’s index, Simpson’s Evenness, Shannon Diversity, 
Species Richness, and the Chao1 index.  It is important to note that the Chao1 index is a 
measurement of species richness.  These diversity indices were calculated using the species level 
data, which was part a Qiime2 output.  A bar plot was then used to visualize the Shannon Diversity 
of the species present in all samples, with an overlaid plot indicating the species richness. 
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Multivariate Analyses 
Multivariate analyses were implemented to observe the taxonomic relationships across wastewater 
samples.  Nonmetric multidimensional scaling is a type of ordination technique (Holland, 2008) 
that can be used on a wide array of large datasets (Holland, 2008, Jiang et al. 2010).  The NMDS 
method has been described as a highly flexible and preferred method for evaluating multi-
dimensional data that does not follow normality assumptions (Dexter et al. 2018).  Compared to 
other types of similar analyses, such as a principal component analysis, NMDS does not assume 
linear or modal relationship for a dataset (Holland 2008, Jiang et al. 2010, Kenkel, 1986).  The 
algorithm utilized by NMDS ranks the distances between points within a dataset, which are then 
used to map the objects on a non-linear two-dimensional ordination (Kenkel 1986, Ramette 2007).  
Different types of distance measures can be used to evaluate a specific dataset (Holland, 2008), 
such as Bray-Curtis or Euclidian distances (Kruskal, 1964).  An NMDS can be adjusted by rotation 
or inversion to view any preferred data arrangement (Holland, 2008, Jiang et al. 2010).  This 
method is extremely useful because it allows us to evaluate complex data in reduced dimensions 
and has been used to in ecological research to evaluate community abundance (Dexter et al. 2018).  
However, the success of NMDS may be dependent upon the standardization of data prior to 
analysis (Kenkel, 1986), and the analysis can be very slow with large datasets (Holland, 2008).  
Another drawback to NMDS is that the method can fail in determining the best solution for a 
dataset if it becomes stuck on minimal solutions that may not be the best solution for a particular 
dataset (Holland, 2008).  Despite some draw backs of the method, NMDS NMDS been used in 
microbial ecology (Ramette, 2007) because it can identify underlying gradients influencing 




To perform nonmetric multidimensional scaling within R studio, the Jaccard and Bray-Curtis 
dissimilarities were found using the vegdist function via the Vegan package.  While both of these 
distances were calculated, the Bray-Curtis distances was used for non-metric multidimensional 
scaling (NMDS). An NMDS was produced using R studio, and the NMDS values for the Bray-
Curtis distances were extracted from the program. The scores that resulted from the Bray-Curtis 
dissimilarities were then analyzed using the isoMDS function in R. This function implements 
Kruskal’s non-metric dimensional scaling to minimize the stress values for the points. This 
function generates an NMDS from the Bray-Curtis dissimilarities calculated prior in the code. As 
a general rule, the lower the stress values for the data points, the more accurate the NMDS analysis. 
The metaMDS function was also used to combine inner functions within R to run the NMDS.  The 
water quality and PPCP data were then put onto an ordination using the envfit function, with 999 
permutations specified for all analyses.  The scores from the NMDS analyses that were calculated 
using R were extracted and then imported into MATLAB for visualization. 
 
Once the data were imported into MATLAB, the NMDS scores for each sample were plotted in a 
scatter plot, alongside the NMDS scores for the environmental parameters included in the analysis.  
Four NMDS analyses were run in R, and three of these were plotted in MATLAB.  The first NMDS 
was made to better understand the microbial species diversity of all 25 samples, while the second 
NMDS was made to evaluate the influence of water quality parameters on microbial phyla.  The 
last NMDS included in this study was performed with the goal of evaluating the influence PPCPs 
may have upon microbial phyla in the wastewater samples.  The NMDS process in R and 
MATLAB described above was used for each NMDS presented in this study. 
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Results and Discussion 
Dominant Microbial Domains and Phyla 
The dominant microbial domain for each wastewater treatment facility was evaluated by summing 
up the number of sequence ‘hits’ for each sample by WWTF, and calculating the percent 
abundances for each domain.  The chart presented in Figure 4.1 indicates that bacteria is the most 
dominant domain for each of the four WWTFs, the data from which was obtained through 16S 
rRNA gene sequences.  Due to difficulty in viewing the archaea and unassigned abundances in 
Figure 4.1, a table summarizing this information can be seen in the attached supplemental 
information (Table D1.2).  As was hypothesized, bacteria comprised greater than 90% of all 
samples, with archaea constituting less than 10%.  Based on 16S rRNA sequence data, which may 
bias results toward bacteria, the only facility where archaea were detected was WWTF 4, which 
implements the Bardenpho design.  WWTF 2 showed all sequence identified as bacteria, while 
WWTFs 1, 3, and 4 had less than 1% unassigned.
 78 
 
Figure 4.1: The percent abundance of Archaea, 
Bacteria, and Unassigned microorganisms using 
Illumina16S rRNA gene sequencing results. 
 
Figure 4.2: The percent abundance of Archaea, 
Bacteria, Eukaryota, Viruses, and other sequences 
using Illumina metagenomic sequencing results
The results from the metagenomic sequencing presents a similar but complimentary story, as this 
approach can detect prokaryotes, eukaryotes, and viruses. Metagenomic data (Figure 4.2) showed 
bacteria were the dominant domain for all WWTF samples, comprising a minimum of 98% relative 
abundance of sequences in each WWTF. Archaea were detected in all facilities, but found to 
constitute less than 0.6% relative abundance, while eukaryotes were found to constitute between 
0.87 and 1.2% across the WWTFs. Viruses were identified in very small percent abundances across 
the facilities, with the highest detection found in WWTF 2 (~0.047%).  A table summarizing the 
percent abundances for each domain via metagenomics sequencing can be found in the 
corresponding supplemental information (Table D1.2).  The findings of both the 16S rRNA gene 
sequencing and metagenomic sequencing analysis indicate that the majority of the microorganisms 
that are present in wastewater treatment are indeed bacteria.  These results serve as the basis for a 
deeper search into who these members are and what functions they may serve within treatment 
processes.   
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The dominant microbial phyla for each WWTF were evaluated using the RefSeq database through 
MG-RAST.  The results of this analysis (Figure 4.3), which shows the percent abundance of 
microbial phyla in each facility.  These findings are consistent with previous research in the field. 
The top six dominant phyla for WWTF 1 included, Proteobacteria, Actinobacteria, Bacteroidetes, 
Firmicutes, Planctomycetes, and Chloroflexi.  WWTF 2 was dominated by Proteobacteria, 
Bacteroidetes, Actinobacteria, Firmicutes, Verrucomicrobia, and Chloroflexi, respectively.  
WWTF 3 consisted of the following top six dominant; Proteobacteria, Bacteroidetes, 
Actinobacteria, Chloroflexi, Firmicutes, and Planctomycetes.  Lastly, WWTF 4 consisted of the 
following dominant phyla; Proteobacteria, Bacteroidetes, Actinobacteria, Firmicutes, and 
Verrucomicrobia, and Planctomycetes. Proteobacteria comprised 52 to 61% of the microbial 
community members across WWTFs, while Actinobacteria constituted about 7 to 17%.  
Wastewater treatment facility 3 contained the largest abundance of Bacteroidetes (18%) and 
Firmicutes (3%). This facility also contained the largest percent abundance of Plancomycetes 
(~2%), while WWTF 2 contained the least abundance for this phylum (1.6%).  Chloroflexi was 






Figure 4.3: The Relative abundance of the microbial phyla within each wastewater treatment facility, detected using 
Metagenomics Illumina Sequencing and retrieving matching sequences from KO database in MG-RAST.  Phyla are 




The microbial diversity for each sample was determined using the Vegan package in R studio, 
using the 16s rRNA sequencing results.  The Shannon Diversity as well as the species richness 
were visualized in one figure displaying how these indices varied between samples (Figure 4.4).  
In Figure 4.4, the Shannon Diversity indices are depicted as bar plots, corresponding to the left y-
axis.  In general, a larger Shannon Diversity index indicates higher microbial diversity, and a larger 
species richness value indicates a higher microbial species richness.  The species richness for each 
sample is indicated by an asterisk and corresponds to the values indicated on the secondary, right 
y-axis.  It can be seen that the highest microbial diversity for WWTFs 1 and 4 was observed for 
the sludge samples.  The highest diversity for WWTF 2 was almost tied for the sludge and Zone 1 
of secondary treatment.  Interestingly, sludge was found to have the lowest microbial diversity of 
all samples for WWTF 3.  Although these results were not expected, the sludge Shannon Diversity 
indices for WWTFs 1, 2, and 4 support our diversity prediction.  WWTF 3, which exhibited the 
lowest sludge diversity, was the youngest facility sampled, had the second shortest solids retention 
time, and the longest hydraulic retention time.  The influence of solids retention time was explored 
through NMDS analysis, however statistical analyses deemed it insignificant in the current study.   
 
The treatment facility implementing an oxidation ditch for secondary treatment was expected to 
have the lowest microbial diversity out of the WWTFs.  The average Shannon Diversity index was 
highest for WWTF 2, followed by WWTF’s 4, 1, and 3.  Additionally, the top two WWTFs with 
the highest Shannon diversity were those that utilized the Bardehpho system.  All sludges, except 
for WWTF 3, had a species richness above 250.  The secondary effluent sample from WWTF 2 
exhibited the lowest species richness of any sample, which was calculated at 61.  It is important to 
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note that the influence of secondary settling, in which settling basin is implemented at end of 
secondary treatment to separate liquids and solids before wastewater if sent for the next stage of 





Figure 4.4: A visual representation displaying the Shannon Diversity indices (left y-axis) and species richness (right 
y-axis) for each sample.  Shannon diversity is represented through the bar plot, while species richness is indicated by 
the asterisks. Colors indicate specific treatment facilities; WWTF 1=blue, WWTF 2=pink, WWTF 3=red, and 
WWTF=yellow.  BH and AH indicate the anoxic and aerobic sections of WWTF 1’s oxidation ditch, respectively. Z1 
and Z3 indicate the primary and secondary anoxic sections of 4-stage Bardenpho, while Z2 and Z4 indicate the primary 
and secondary aerobic sections of 4-stage Bardenpho for WWTFs 2, 3, and 4. 
 
In addition to evaluating the microbial diversity and species richness for each sample, the presence 
of antibiotics in secondary influent, secondary effluent, and sludge was evaluated.  As can be seen 
in Table 4.1, at least one antibiotic was detected in each sample.  The sludge sample for WWTF 2 
had the highest Shannon Diversity and species richness, and only one antibiotic was detected in 
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the sample.  The lowest Shannon Diversity was seen for WWTF 3’s sludge sample, while the 
lowest species richness was observed for the secondary effluent of WWTF 2.  Three different 
antibiotics were detected in each of these facilities.  Interestingly, the most frequently detected 
antibiotic for all samples was Trimethoprim.  While it cannot be explicitly stated that antibiotics 
decrease microbial diversity, the results presented in this report support the need for further 
research regarding the influence that these compounds of emerging concern may have on 
wastewater microbial communities. 
Table 4.1: The Shannon Diversity and Species Richness for the secondary influent, secondary effluent, and sludge 
samples from each WWTF, alongside the number of antibiotics detected and the PPCP detected at the highest 




It is possible that some of the organisms that constituted some of the diversity seen in the samples 
taken within secondary treatment basins (e.g., BH, AH, Z1, Z2...) may be associated with 
organisms that prefer to adhere to particles, as opposed to the free swimmers that may be found in 
the liquid regions of wastewater treatment.  Therefore, the secondary settling basin has the 
potential to concentrate these diverse organisms with an affinity for surface growth to settle out 
into the sludges, possibly influencing the diversity observed in the sludges for the sampled 
WWTFs. 
WWTF ID Sample ID Shannon Diversity Species Richness Antibiotics detected Highest Concentration
WWTF 1 Sin 3.64 135 3 Azithromycin
WWTF 1 Sout 4.53 245 3 Trimethoprim
WWTF 1 Sludge 4.65 271 1 Trimethoprim
WWTF 2 Sin 4.66 279 3 Ciprofloxacin
WWTF 2 Sout 3.61 61 3 Trimethoprim
WWTF 2 Sludge 4.93 306 1 Trimethoprim
WWTF 3 Sin 3.81 169 4 Sulfamethoxazole
WWTF 3 Sout 4.27 190 4 Ciprofloxacin
WWTF 3 Sludge 3.57 201 3 Trimethoprim
WWTF 4 Sin 4.04 193 4 Ciprofloxacin
WWTF 4 Sout 4.55 246 4 Azithromycin
WWTF 4 Sludge 4.90 299 2 Trimethoprim
 84 
Multivariate Analyses 
Non-metric multidimensional scaling (NMDS) was implemented to observe similarities between 
the microbial classes found at the sampled WWTFs via 16s rRNA sequencing, as well how water 
quality and the presence of PPCPs may influence the microorganisms in wastewater treatment.  An 
NMDS was performed using microbial class data for all 25 WWTF samples.  The results of this 
analysis, seen below in Figure 4.5, indicated that the zones within each secondary treatment 
process were closely related by WWTF.  Interestingly, the influent samples for WWTFs 1, 3, and 
4 are grouped quite a distance away from the other wastewater samples, indicating a significant 
difference in their microbial classes when compared to the other samples.  The sludge for WWTF 
1 is oriented very closely to the samples taken from the secondary treatment zones for that facility, 
while the sludge samples for the other WWTFs are oriented at a further distance from their 
respective WWTF secondary treatment zone samples.  The results from this NMDS indicate that 
the microbial classes detected in the outlying samples may be more unique than those that are 
grouped closer together, such as the samples taken from within the different secondary treatment 
zones.  It was expected that the Bardenpho system would select for different taxa based on the 
series of aerobic and anoxic environments provided in the treatment process, however these 
samples were for the most part grouped closely together within the NMDS. 
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Figure 4.5: A non-metric multidimensional scaling (NMDS) analysis calculated using Bray-Curtis distances between 
all WWTF samples.  WWTF 1 is shown in dark blue, WWTF 2 is shown in light blue, while WWTF’s 3 and 4 are 
shown in red and green, respectively.  An X indicates a secondary influent sample, and a circle indicates secondary 
effluent.  A triangle indicates samples taken within secondary treatment basins, while an asterisk is representative of 
a sludge sample. 
 
Another goal of this study was to observe the influence PPCPs may have on wastewater microbial 
taxa.  An NMDS was performed to evaluate this, and three PPCPs were found to be statistically 
significant, with p-values less than 0.05 each.  The samples analyzed for this NMDS included 
secondary influent, secondary effluent, and sludge.  As seen in Figure 4.6, the significant PPCPs 
included sulfamethoxazole, TDCPP, and DEET.  Sulfamethoxazole is a very common antibiotic 
used to treat bacterial infections.  TDCPP is a type of flame retardant, and DEET is a frequently 
used insect repellent.  Sulfamethoxazole and TDCPP appear to have a similar trajectory within the 
NMDS, indicating that they may have a similar association to the microbial phyla in these 
wastewater samples.  DEET appears to be driving the separation of the microbial communities 
similiar to sulfamethoxazole and TDCPP, but with a more southern trajectory.  It can be seen in 
Figure 4.6 that these PPCPS may have a higher influence on secondary influent for WWTFs 1, 3, 
and 4 than the other samples present.  It also appears that the remaining wastewater samples are 
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not as heavily influenced by these PPCPs. This seems appropriate, considering that wastewater 
entering secondary treatment has not been treated yet and may contain higher concentraitons of 
pollutants than wasewater further along the treatment train.  A step-by-step procedure on how the 
NMDS exhibited in Figure 4.6 was developed can be found in Appendix C.  This procedure applies 
to all of the NMDS figures developed in this chapter. 
 
Figure 4.6: NMDS calculated using Bray-Curtis distances between secondary influent (Sin, X), secondary effluent 
(Sout, •), and sluge (*) samples for each WWTF.  WWTF 1 is shown in dark blue, while WWTF 2 is shown in light 
blue.  WWTFs 3 and 4 are shown in red and green, respectively.  Sulfamethoxazole, TDCPP, and DEET were the 
only PPCPs found to be significant in the statistical analysis, as they each had a p-value lower than 0.05. 
 
The final objective of this study was to evaluate the influence of water quality parameters and 
operational conditions on wastewater microbial taxa.  An NMDS was performed to evaluate solids 
retention time (SRT) in relation to taxa detected via 16s rRNA sequencing, however statistical 
analyses regarded this parameter as insignificant, with a P-value greater than 0.05.  An NMDS was 
also performed using the water quality parameters recorded for secondary influent and secondary 
effluent samples.  Five parameters were found to be significant; ammonia, total dissolved nitrogen 
(TDN), non-purgeable organic carbon (NPOC), chemical oxygen demand (COD), and redox 
potential.  Each of these parameters received a P-value less than 0.05.  Ammonia and TDN appear 
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to have a very similar influence on the microbial taxa, which is reasonable considering that 
ammonia is a compound that contains nitrogen.  These two parameters, in addition to NPOC, 
appear to have an influence on the microbial phyla present in the secondary effluent of WWTFs 3 
and 4.  COD has a north-west trajectory, and may have a slight impact on secondary effluent as 
well.  The oxidation-reduction reaction (redox) potential appears to have an influence on the phyla 
for some of the secondary effluent samples, including a trajectory directly through secondary 
effluent sample for WWTF 3 in Figure 6.  The secondary influent sample for WWTF 1 appears to 
be an outlier for microbial phyla within the NMDS.  WWTF 1 was the only facility sampled that 
performs secondary treatment using an oxidation ditch. 
 
Figure 4.7: NMDS evaluating the influence of statistically significant water quality parameters on the microbial Phyla.  
Secondary influent (Sin, X), secondary effluent (Sout, •), and sludge (*) samples were included in this specific 
analysis.  TDN signifies total dissolved nitrogen, non-purgeable organic carbon is specified by NPOC, and COD 
indicates chemical oxygen demand. 
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Biodegradation Enzymes 
To begin an analysis of the enzymes associated with biodegradation that were present in the 
wastewater samples for this study, enzyme class abundance for the main groups of enzymes 
detected in the samples was evaluated.  Metagenomic data was compared with sequences in the 
KO database using MG-RAST. This approach gave insight into the dominant types of enzymes in 
the secondary treatment basins at each WWTF.  The results of this analysis, which can be seen 
below in Figure 4.8, indicates that the percent abundance of enzyme classes detected across the 
WWTF samples remained fairly consistent.  Percent abundance, which was calculated for each 
class in comparison to the total number of sequence ‘hits’, was highest for “other” enzymes within 
the KO database.  The most dominant class for each WWTF was the hydrogenase enzyme group, 
which constituted approximately 10% of enzyme classes in each WWTF.  Transferase enzymes 
constituted about 9% in each facility while the synthases comprised about 8% of detected enzymes 





















Figure 4.8: The percent abundance of different enzyme classes found in each treatment facility using the KO database 


















Figure 4.9: The Percent abundance of cellular activity for each WWTF, retrieved from KO databases.  Abundances 
were calculated from using the total number of sequence ‘hits’ for each WWTF. 
 
It can be seen in figure 4.9 that the major cellular activities occurring in each facility fell under 
‘metabolism,’ accounting for around 60% of all cellular activity for each WWTF.  This was 
followed by genetic information processing, environmental information processing, cellular 
processing, human diseases, and lastly organismal systems.  A closer look into the metabolic 
activities for the samples can be seen in Figure 4.10, below.  The results presented in Figure 4.10 
indicate that the majority of metabolic activity at each WWTF is associated with amino acid 
metabolism.  Amino acids have been regarded as the building blocks of proteins, supporting the 
survival and growth of microorganisms (Morowitz et al. 2011).  Additionally, amino acids are also 
described to promote protein homeostasis and energy regulation (Bergen and Wu, 2009, Metges 
2000).  Metabolism activity related to xenobiotic biodegradation and metabolism accounted for 
less than 2% of all metabolic activity at each WWTF (WWTF=1.84% ; WWTF2=1.89% ; 
WWTF3=1.8% ; WWTF4=1.86%).  ‘Xenobiotic’ is a general term used to describe any compound 
or substance that is not native to an organism or ecosystem, and PPCPs fall under this category.  It 
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was predicted that metabolism related to micropollutant or xenobiotic degradation would comprise 
less than 10% of cellular activity for each WWTF.   
 
It is important to note that the categories defined in Figures 4.9 and 4.10 are defined the KO 
database used within MG-RAST to evaluate cellular and metabolic activity.  It is quite possible 
that PPCP-degrading enzymes are present within the other metabolic activity categories (e.g. 
amino acid metabolism, energy metabolism).  This current chapter focused on the “xenobiotics 
biodegradation and metabolism” category from the KO database.  Therefore, it import to recognize 
that there are thousands of other enzymes included in the categories displayed in Figure 4.10, some 
of which may have the ability to catalyze PPCP-degradation reactions, and possibly even enzymes 





















Figure 4.10: The percent abundance of metabolic activity for each WWTF. 
 
While there are many enzymes suspected to play a role in the biodegradation of different PPCP 
compounds, this study focused on four enzymes that have been described to aid in the degradation 
of four compounds highlighted in our research.  These compounds included carbamazepine, 
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sulfamethoxazole, DEET, and caffeine.  A 2012 study by Keen et al. found that the advanced 
oxidation of carbamazepine facilitated catechol deoxygenate in opening the aromatic rings of the 
compound, allowing the products to be further mineralized and degraded by microorganisms 
within activated sludge.  A search for PPCP-degrading enzymes on the Swiss Federal Institute of 
Aquatic Science and Technology (EAWAG) Biocatalysis/Biodegradation Database also identified 
degradation enzymes of interest (Swiss Federal Institute of Aquatic Science and Technology, 
2017).  This database indicated that trimethylamine dehydrogenase and xanthine 
dehydrogenase/oxidase have been documented to degrade DEET and caffeine, respectively.  
Additionally, Larcher et al. (2011) described the enzyme arylamine N-acetyltransferase as capable 
of degrading sulfamethoxazole, due to its ability to use the antibiotic as a substrate by utilizing its 
aromatic amine.  An analysis exhibiting the percent abundance of PPCP biodegradation enzymes 
of interest discussed in Chapter 1 (Table 1.1) can be seen in Figure 4.11, below.  Our findings 
suggest that the most abundance degradation enzymes that were targeted based on the literature 
presented in Table 1.1 were Catalase-Peroxidase, Nitronate Monooxygenase, and Glutathione 
Peroxidase.  Current literature indicates that the classes these enzymes belong to can catalyze the 
biodegradation of pharmaceuticals (Varga et al. 2019) and emerging organic contaminants (Deng 
















Figure 4.11: The relative abundance of enzymes indicated by literature to catalyze PPCP biodegradation.  Results are 
shown in relative abundance of individual enzymes. 
 
The four enzymes described to degrade carbamazepine, sulfamethoxazole, DEET, and caffeine 
were evaluated in the context of the WWTFs sampled in this study.  The percent abundance of the 
degradation enzymes in each facility can be seen below in Table 4.2.  Also presented it the table 
are the genes associated with each enzyme, in addition the enzyme identification numbers (EC).  
Two types of catechol dioxygenase enzymes were found in the WWTF samples; Catechol 1,2 
Dioxygenase and Catechol 2,3 Dioxygenase.  Wastewater treatment facility 1 contained the 
highest percent abundance of Catechol 1,2 Dioxygenase (0.0062%), while WWTF 4 contained the 
highest abundance of Catechol 2,3 Dioxygenase (0.0155%) and Xanthine Dehydrogenase 
(0.0063%) .  Facility 1 also contained the highest abundance of Trimethylamine Dehydrogenase 
(0.0032), while the highest abundance for Arylamine N-Acetyltransferase was observed in WWTF 
2 (0.0021%).  While the presence of these enzymes in the WWTF microbial samples indicates that 
removal of these compounds during treatment processes could be occurring through 
 93 
biodegradation, their presence alone does not indicate whether or not a biodegradation pathway is 
active. 
Table 4.2:  Four enzymes that have been suspected to play a role in the degradation of carbamazepine, DEET, 
Sulfamethoxazole, and Caffeine.  Also included in the table are the genes associated with each enzyme, in addition to 
the enzyme identification numbers (EC) and the relative abundance of each enzyme in the WWTFs sampled. 
 
 
To evaluate the removal efficiency of the four compounds corresponding with the detected 
biodegradation enzymes, the percent removal was calculated and plotted alongside enzyme percent 
abundance (Figure 4.12).  Percent removal was calculated as the difference between secondary 
influent and secondary effluent PPCP concentrations (ng/L), divided by the secondary influent 
concentration (ng/L).  This value was then multiplied by 100 to find percent removal.  Enzyme 
abundance was calculated by dividing the number of sequence ‘hits’ by the total gene count for 
each WWTF sample.  The resultant value was then multiplied by 100.  DEET and caffeine, both 
classified as personal care products, were observed to be removed by greater than 90% for each 
facility except for WWTF 2, in which DEET decreased about 79% from secondary influent to 
secondary effluent.  The greatest percent removal for DEET was observed for WWTF 4 (99.28%).  
WWTF 4 had the highest abundance of the caffeine-degrading enzyme Xanthine 
Dehydrogenase/Oxidase (0.0063%) and was observed to perform the greatest removal of caffeine 
(99.95%) compared to the other WWTFs.  The least efficient removal of caffeine was seen in 
WWTF 2 (93.93%), a facility that was found to contain about 0.0025% abundance of Xanthine 
Dehydrogenase/Oxidase. 
 
Enzyme PPCP WWTF 1 WWTF 2 WWTF 3 WWTF 4
catA; catechol 1,2-dioxygenase [EC:1.13.11.1] 0.0062 0.0041 0.0060 0.0033
dmpB; catechol 2,3, dioxygenase [EC: 1.13.11.2] 0.0149 0.0113 0.0129 0.0155
trimethylamine dehydrogenase [EC:1.5.8.2] DEET 0.0032 0.0025 0.0022 0.0019
nat; arylamine N-acetyltransferase [EC:2.3.1.5] Sulfamethoxazole 0.0020 0.0021 0.0014 0.0019
XDH; xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2] Caffeine 0.0015 0.0025 0.0014 0.0063
Carbamazepine
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The removal efficiency for the pharmaceuticals carbamazepine and sulfamethoxazole varied 
greatly, as can be seen in Figure 4.12.  Positive removal for carbamazepine was observed in 
WWTFs 2 and 4, at about 44.08% and 83.60% for each facility respectively.  Negative removal, 
an increase in secondary effluent from influent, was seen in WWTFs 1 and 3.  Although WWTF 
1 had the highest percent abundance of carbamazepine-degrading enzymes Catechol 1,2 
Dioxygenase and Catechol 2,3 Dioxygenase compared to the other facilities (0.021%), this facility 
was found to exhibit a significant negative removal of this compound (- 415.5%).  WWTF 1 also 
contained the highest percent abundance of the sulfamethoxazole-degrading enzyme Arylamine 
N-acetyltransferase (0.0032%) and exhibited the greatest percent removal for sulfamethoxazole 
(80.40%).  Unexpectedly, the lowest removal for sulfamethoxazole was observed in WWTF 2 (-
64.38%), which contained the highest abundance of arylamine N-acetyltransferase (0.0025%).  
Interestingly, while WWTF 1 was observed to have the greatest negative removal of 
carbamazepine, this facility had greater than 80% removal for sulfamethoxazole, DEET, and 
caffeine.  The greatest removal for sulfamethoxazole was seen in WWTF 1 (80.40%) and the 
lowest percent removal was observed in WWTF 2 (-64.38%).  The highest average percent 
removal was seen for WWTF 4, with an average removal of 75.06% for the four target compounds.  
These results indicate that WWTF 4, which implements the Bardenpho system for secondary 
wastewater treatment, appeared to be the most efficient facility at removing carbamazepine, 
sulfamethoxazole, DEET, and caffeine.  The results presented in Figure 4.12 indicate that while a 
specific WWTF may have a higher abundance of enzymes associate with PPCP biodegradation, 
this may not necessarily mean that greater PPCP removal is occurring during treatment.  It is also 
important to note that this specific analysis focused on only 4 of the 21 compounds detected in the 
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four WWTFs, and that there may be many other compounds present that remained below the 




Figure 4.12: The removal efficiency and enzyme abundance for carbamazepine, sulfamethoxazole, DEET, and 
caffeine in the four WWTFs sampled.  Blue bars correspond to the left y-axis and indicate percent PPCP removal.  
Red dots (•) correspond to the right y-axis and represent the percent abundance of each degradation enzyme 
highlighted in Table 4.2.  For Carbamazepine, enzyme abundance is representative of the sum of Catechol 1,2 
Dioxygenase and Catechol 2,3 Dioxygenase, both enzymes that have been described to catalyze carbamazepine-
degradation reactions. 
 
Conclusions and Implications 
The findings presented in this study may serve as a foundation for a deeper understanding on the 
diversity and function of wastewater microbial communities.  Bacteria comprised over 90% of all 
microbial samples, while eukaryotes made up less than 10% of each sample, as was hypothesized.  
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Archaea was also found to encompass less than 1% of microorganisms within each WWTF.  Three 
out of the four sludges samples exhibited the highest microbial diversity for their respective 
WWTF.  The highest species richness was measured in the sludge of WWTF 2, where only one 
antibiotic was detected. This same facility also exhibited the highest Shannon Diversity.  The 
lowest Shannon Diversity index was observed for the sludge sample of WWTF 3, in which three 
antibiotics were detected. Interestingly, four antibiotics were detected in the secondary effluent of 
WWTF, however this sample had a Shannon Diversity above 4.5 and a species richness of 246, 
both of which are relatively high compared to the remaining samples.   
 
While some samples in which a higher number of antibiotics were detected did demonstrate lower 
species diversity indices compared to the other samples, more research would be needed to 
determine whether or not it the presence of antibiotics that causes lower diversity.  Five enzymes 
associated with the degradation of four PPCPs were found in small abundances in each facility.  
However, this analysis only scratches the surface of the biodegradation enzymes found in 
wastewater treatment, a field of research that is still relatively uncharted.  The findings of this 
study give a glimpse into a complex and diverse microbiome that is not yet fully described.  This 
research also highlights the potential of wastewater microbial communities to degrade pollutants, 
alongside the factors that can influence the efficiently of biodegradation.  A deeper exploration of 
the wastewater microbiome can lead to advances in wastewater treatment, which can improve the 
quality of environmental and human health. 
 
By characterizing the microbial communities found in wastewater treatment unit processes, we 
can further understand their metabolic potential, including the presence of enzymes involved in 
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PPCP degradation.  It is possible that organisms that are found in low abundance contribute to 
micropollutant removal, having an advantage through a specialized niche (Saunders et al. 2016). 
The microorganisms and the functions they serve ultimately determine the performance of 
wastewater treatment (Fang et al. 2018).  Microbial diversity has been linked with positive 
pollutant removal, and an understanding of the factors influencing how a microbial community is 
structured allows for the optimization of biological treatment processes, increased biodiversity, 
and improvement of nutrient and pollutant removal (Wu et al. 2019, Zhang et al. 2016). Ma et al. 
(2013) indicated that treatment systems were more stable with higher microbial diversity.  While 
engineers may be able to select microorganisms that are associated with PPCP degradation and 
seed treatment systems with these members, the microbial competitors and operational parameters 
may hinder their survival.  Many factors, such as temperature, pH, solids and hydraulic retention 
times, can impact the fate of targeted microorganisms.  Therefore, more research dedicated 
towards understanding these complex communities is needed.  The current study has shed light on 
a fraction of the microbial diversity present in wastewater treatment, and more studies dedicated 
towards understanding these communities and their associated degradation enzymes is greatly 
needed.  The next steps within this field of research demand further classification of these 
microorganisms, as well as a deeper analysis of the microbial members and the metabolic pathways 








Upon reflection on my thesis, the three projects included in my research have highlighted the need 
for continued monitoring of PPCPs in surface water, the PPCPs partitioning to sludges in 
wastewater treatment that might warrant future monitoring, and the microorganisms and their 
enzymes associated with PPCP degradation within wastewater treatment systems.  Included in this 
chapter is a summary of my findings and recommended future research topics that stem from this 
thesis. 
 
Presence and Concentration of an Extended Antibiotic List in the Great Bay Estuary, 
New Hampshire 
In the analysis of an expanded list of pharmaceuticals and personal care products (PPCPs) in the 
Great Bay Estuary (GBE), I determined that select PPCPs were commonly detected in surface 
water locations in the seacoast region of New Hampshire. Specifically, carbamazepine and 
sulfamethoxazole, an anticonvulsant and antibiotic, respectively, were detected in the Great Bay 
Estuary in both 2019 and 2020.  These results are concerning because even small concentrations 
of antibiotics can have negative effects on aquatic ecosystems and non-target organisms (Meyer 
et al. 2019, Petrie et al. 2015, Sörengård et al. 2019). The source of carbamazepine and 
sulfamethoxazole could be from wastewater treatment discharge but may also include other 
sources unsampled in this thesis (e.g., septic systems). Regardless of their source, given their 
human use, their detection in surface water suggests they are not efficiently removed in community 
or household wastewater systems. Continued monitoring of these compounds in the GBE would 
further our knowledge on the sources, prevalence, and seasonal fluctuation of these compounds. 
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Additional monitoring for PPCPs in the GBE may also provide insight into whether COVID-19 
lockdown procedures during 2020 and/or 2021 impacted PPCP concentrations and detections and 
assist seacoast communities identify sentinel compounds that may pose risk to aquatic species.  
Although outside the scope of this thesis, experiments assessing the toxicity of PPCPs is 
recommended, especially for mixtures of pharmaceutical compounds common in this region. 
 
Partitioning of 21 Pharmaceuticals and Personal Care Products into Aqueous and 
Solid Phases During Wastewater Treatment 
An analysis on aqueous and sludge concentrations of PPCPs revealed that pharmaceuticals were 
higher in relative abundance compared with personal care products.  We measured personal care 
products at higher concentrations than pharmaceuticals in all stages of treatment.  A review of the 
partition coefficient (KD) values for PPCPs analyzed in our study indicated that compounds such 
as azithromycin, ciprofloxacin, trimethoprim, phenytoin, primidone, diazepam, fluoxetine, and 
DEET should be found at higher abundances in wastewater sludges while the other tested 
compounds showed lower KD values in the literature should be found in higher abundance in 
aqueous phases.  In accordance with these coefficients, we found a high abundance of 
ciprofloxacin and fire retardants in the sludges of four WWTFs sampled, indicating that these 
compounds readily sorbed to sludge. Another pharmaceutical detected in sludge samples was 
fluoxetine while three personal care products (TCPP, TDCPP, and caffeine) were also commonly 
detected in the sludge. Research regarding KD values for fire retardants is needed, as these were 
found in high abundances in wastewater sludge yet I as unable to locate KD values for TCPP and 
TDCPP in the existing literature.  It is important to note that KD values are determined 
experimentally using standard methods (OECD, 2000) and vary based on the type of media used. 
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Notably, adsorption coefficients relevant to wastewater sludge may differ considerably from soils 
because of system pH, the amount of organic carbon in the solids, and other parameters. As a 
result, future experiments could measure adsorption coefficients for PPCPs using solids more 
representative of sludge. This is especially important as fire retardants were found in high 
abundances in all WWTF sludges in my research, however literature regarding their KD values is 
lacking. Research which investigates how PPCPs may be transforming during biological treatment 
and disinfection processes is also needed, as we observed a decrease in antibiotics and an increase 
in fire retardants in our chlorination and dechlorination samples.  
 
The Microbial Communities and PPCP Degrading Capability of Wastewater Taxa 
The 16S rRNA gene sequencing and metagenomics analysis indicated dominant microbial phyla 
observed in NH WWTFs were in agreement with those observed in the current literature for other 
WWTFs. Non-metric multidimensional scaling (NMDS) indicated that sulfamethoxazole, TCPP, 
and DEET exhibited significant influence on microbial classes in wastewater samples, specifically 
those communities in the secondary influent. These results indicate that these compounds may 
partially drive the composition or diversity of microbial taxa present in certain unit processes of 
wastewater treatment.  
 
Sludges in particular, had higher Shannon diversity indices relative to water samples given their 
accumulation and recycling within the facility. A better understanding on how composition and 
diversity of sludges changes through time, particularly related to operational parameters, could 
yield insight into treatment efficiency and processes. While multiple enzymes associated with 
PPCP degradation were identified in our study through metagenomic evaluation, my work on this 
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subject only scratched the surface of the metabolic potential of wastewater microbial communities 
in NH.  Wastewater in general is a very complex matrix, sludges even more so, and the use of 
advanced analytical techniques could help shed light on the microbial communities of sludges and 
the PPCPs they can degrade.  Further investigation into metabolic potential in wastewater 
treatment, and which pathways are active, is an area in need of research so we can advance our 
understanding on the biotransformation of these compounds during different treatment processes.  
We recommend research that targets metabolic pathways of wastewater microbial communities in 
order to evaluate how these organisms interact under the influence of varying conditions, including 
the presence and concentration of PPCPs. 
 
Conclusions 
During the completion of my thesis, I also learned that while I did make contributions to the field 
contaminants of emerging concern, this is complex and evolving field of research.  Not only are 
there many different types of pollutants that are received in municipal wastewater treatment 
facilities, but there are so many factors that influence how these compounds behave during 
wastewater treatment processes, and ultimately their fate in the environment.  The microbial 
communities of wastewater also remains an area that scientists and engineers have yet to fully 
understand, as these communities can be very complex, and vary across treatment types, processes, 
and regions.  Additionally, although multiple degradation enzymes were found that could catalyze 
PPCP biotransformation in these NH WWTFs, their presence alone does not indicate if these 
pathways are active. A combination of advanced fractionation research, enzymatic and 
biodegradation analyses, in addition to continued monitoring of PPCPs in wastewater and surface 
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water can help advance our knowledge’s on contaminants of emerging concern and their fate in 


























APPENDIX A: Supplemental Information for Chapter 1 
 
Table A1.1: The different factors described to influence the removal of PPCPs in wastewater treatment.  Green text 
indicates the factors that also influence the fractionation of PPCPs to sludge. 
 
Factor Source
Community the treatment facility serves Helbling et al., 2015
Season Tiwari et al., 2017; Verlicchi et al., 2012
Chemical structure & bioavailability of pollutant Tiwari et al., 2017
Pollutant redox potential Tiwari et al., 2017
Pollutant pH Tiwari et al., 2017
Stereo chemical structure of pollutant (molecular 
structure) Tiwari et al., 2017 (Gaffney et al., 2017)
Pollutant Chemical Properties (complexity stability) Dubey et al., 2021; Tiwari et al., 2017; Verlicchi et al., 2012
Solubility of pollutant Tiwari et al., 2017
Volatility of pollutant Tiwari et al., 2017
Photodegradation Tiwari et al., 2017
Biodegradability of pollutant Mohaptra et al., 2021; Tiwari et al., 2017
Sludge retention time of WWTF
Carucci et al., 2006; Chen et al., 2012; Clara et al., 2005; 
Gaffney et al., 2017; Jelic et al. 2011; Kreuzinger et al., 2004; 
Pomies et al., 2013; Strenn et al., 2004; Suarez et al., 2010; 
Tiwari et al., 2017; Tiwari et al. 2018
Hydraulic retenton time of WWTF
Archer et al. 2017; Blair et al. 2015; Chen et al. 2012; Gaffney 
et al., 2017; Pomiés et al. 2013; Tiwari et al. 2017, 
pH of WWTF
Dubey et al., 2021; Horsing et al., 2011; Polesel et al., 2015; 
Pomiés et al., 2013; Twiari et al., 2017
Temperature of treatment process
Dubey et al. 2021; Gaffney et al. 2017; Liu et al. 2016; Pomies 
et al. 2013; Tiwari et al. 2017
Compound Kow (solubility)
Angeles et al., 2020; Mohaptra et al., 2021; Pomiés et al., 2013; 
Tiwari et al., 2017
WWTF type Gaffney et al., 2017
Pollutant Physiochemical Properties
Archer et al., 2017; Gaffney et al., 2017; Pomiés et al., 2013; 
Rostvall et al., 2018
Weather/climate (WWTF Location) Archer et al., 2017; Gaffney et al., 2017 (Verlicchi et al., 2012)
WWTF Microbial Activity; Biomass Concentration Archer et al., 2017; Gaffney et al., 2017
Oxidation Reduction Conditions Pomies et al., 2013
Sludge Characteristics (pH, Cation concentration 
Natural Organic Matter) Chen et al., 2012; Jelic et al., 2011
Sludge treatment methods Chen et al., 2012, Pomiés et al., 2013
WWTF Operational conditions Dubey et al., 2021
Molecular Weight Mohaptra et al., 2021
Kpa Mohaptra et al., 2021
Ionic interactions Blair et al., 2015
Electrostatic reactions Polesel et al., 2015
Surface complexation Polesel et al., 2015
Sludge Type Horsing et al., 2011
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Pollutant Concentration Tian and Wang 2020
Dissolved Oxygen Tian and Wang 2020
Temperature
Tian and Wang 2020; Wu 
et al., 2019
pH Tian and Wang 2020
Wastewater characteristics Tian and Wang 2020
WWTF operational parameters
Cydzik et al., 2016; 
Isazadeh et al., 2016; 
Tian and Wang 2020; 
Tiwari et al., 2017
Influent total phosphorous Tian and Wang 2020
biological oxygen demand
Tian and Wang 2020; Wu 
et al., 2019
NH4+, total nitrogen, total 
phosphorous Tian and Wang 2020
Climate; latitude, altitude; 
geographical location
Isazadeh et al., 2016; Wu 
et al., 2019, Tian and 
Wang 2020
Process type Tian and Wang 2020
Ecosystem size Isazadeh et al., 2016
Ozone treatment Isazadeh et al., 2016
Seasons Isazadeh et al., 2016
Influent characteristics Isazadeh et al., 2016
Aeration efficiencies Isazadeh et al., 2016
Local human gut microbiome Isazadeh et al., 2016
Biotic interactions (competition, 
cooperation) Isazadeh et al., 2016
Local weather effects (rainfall) Isazadeh et al., 2016
watershed effects (soil 
composition) Isazadeh et al., 2016
Chemical stress Isazadeh et al., 2016
Reactor scale Isazadeh et al., 2016
Solids retention time
Isazadeh et al., 2016; 
Tiwari et al., 2017; Wu et 
al., 2019
Influent chemical oxygen 
demand Wu et al., 2019
biological interactions Cydzik et al., 2016
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Table A1.3: The microbial taxa associated with degrading antibiotics, specifically sulfonamides and their 
corresponding references. 
 
Class/Compound Microbial Species Source Biodegradation efficiency Notes
Micropollutants (Ammonia Oxidizing Bacteria (AOB) Kassotaki et al. 2016 degradation Highlights Sulfamethoxazole
Geobacillus thermoleovorans S-07 Pan et al. 2017 degradation
Actinobacteria Reis et al. 2018 degradation
Proteobacteria Reis et al. 2018 degradation
Leucobacter strain GP Reis et al. 2018 degradation
Leucobacter genus Reis et al. 2018 degradation
A. denitrificans strain PR1 Reis et al. 2018 degradation
Brevundimonas sp.  SMXB12 Herzog et al. 2013 degradation
Microbacterium sp. SMXB24 Herzog et al. 2013 degradation
Microbacterium sp. SMX348 Herzog et al. 2013 degradation
Pseudomonas sp. SMX321 Herzog et al. 2013 degradation
Pseudomonas sp. SMX330 Herzog et al. 2013 degradation
Pseudomonas sp. SMX331 Herzog et al. 2013 degradation
Pseudomonas sp. SMX344 Herzog et al. 2013 degradation
Pseudomonas sp. SMX345 Herzog et al. 2013 degradation
Variovorax sp. SMX332 Herzog et al. 2013 degradation
Pseudomonas psychrophila HA-4 Jiang et al. 2014 degradation
Achromobacter denitrif icans PR1 Reis et al. 2014 degradation
Arthrobacter sp. D2 Deng et al. 2016 degradation
Arthrobacter sp. D4 Deng et al. 2016 degradation
Methylobacterium sp. SDZ-W2-SJ40 Mulla  et al. 2016 degradation
S. Oneidensis MR-1 Mao et al. 2018 degradation particularly sulfamethoxazole
Shewanella sp. strain MR-4 Mao et al. 2018 degradation particularly sulfamethoxazole
Achromobacter denitrificans PR1 Reis et al. 2014 degradation particularly sulfamethoxazole
Firmicutes phylum Liao et al. 2016 degradation
Bacteroidetes Phylum Liao et al. 2016 degradation
Flavobacteria Class Liao et al. 2016 degradation
Bacilli Class Liao et al. 2016 degradation
Microbacterium sp. BR1 
Bouju et al., 2012; Ricken et al., 2013; 
Birkigt et al., 2013 mineralization, biodegradation
Rhodococcus sp. BR2 Bouju et al., 2012 mineralization
Achromobacter sp. BR3 Bouju et al., 2012 mineralization
Ralstonia sp. HB1 Bouju et al., 2012 mineralization
Ralstonia sp. HB2 Bouju et al., 2012 mineralization
Achromobacter sp. S-3 Huang et al., 2012 degradation
Brevundimonas sp. SMXB12 Herzog et al. 2013 degradation
Microbacterium sp. (SMXB24, SMX348) Herzog et al. 2013 degradation
Pseudomonas sp. (SMX321, SMX330, SMX331, 
SMX 333*, SMX 336*, SMX 342*, SMX344*, 
SMX345) Herzog et al. 2013 degradation
Variovorax sp. SMX332 Herzog et al. 2013 degradation
Pseudomonas psychrophila HA-4 B.C. Jiang et al. 2014 degradation
Achromobacter denitrificans PR1 Reis et al. 2014, Nguyen et al. 2017 degradation
Acinetobacter sp. W1 Wang and Wang 2018 degradation, mineralization
Rhodopirellula baltica Yan et al. 2012 degradation
Methylibium petroleiphilum PM1 Yan et al. 2012 mineralization
Micrococcus luteus Yan et al. 2012 mineralization
Delftia acidovorans Yan et al. 2012 degradation, mineralization
Oligotropha carboxidovorans Yan et al. 2012 mineralixation, degradation
Achromobacter Wang et al. 2015 degradation
Pseudomonas Wang et al. 2015 degradation
Betaproteobacteria (mainly Thauera) Miran et al. 2018 degradation
Clostridia Miran et al. 2018 degradation
Bacteroidia Miran et al. 2018 degradation
Achromobacter denitrificans strain PR1 Nguyen et al. 2017, Nguyen et al. 2017 degradation
Bacillus subtilis Larcher and Yargeau 2011 degradation
Pseudomonas aeruginosa Larcher and Yargeau 2011 degradation
Rhodococcus equi Larcher and Yargeau 2011 degradation
Microbacterium sp. SMXB24 Herzog et al. 2013 degradation
Brevundimonas sp. SMXB12 Herzog et al. 2013 degradation
Achrombacter sp. BR3 Bouju et al. 2012 degradation
Pseudomonas psychrophila HA-4 Jiang et al. 2014 degradation
Acinetobacter sp. W1 Wang and Wang, 2018 degradation
pseudomonas Jiang et al. 2014, Yang et al. 2018 degradation
achromobacter Jiang et al. 2014, Yang et al. 2018 degradation









Analyte Range Source Media
Acetaminophen 1.6232 Kreuzig R et al; Fresnius Environ Bull 12: 550-8 (2003) test sludge
Amoxicillin 0.0253 Jones et al. 2002 sludge
Giebułtowic et al. 2020 sludge
Sidhu et al. 2019 biosolids (referring to sludge)
Joss et al. 2006 activated sludge
Gobel et al. 2005 activated sludge
Abegglen et al. 2009 activated sludge
Giebułtowic et al. 2020 sludge
Golet et al. 2003 activated sludge
Sidhu et al. 2019 biosolids (referring to sludge)
Hörsing et al. 2011 primary sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Hörsing et al. 2011 secondary sludge, short sludge age
Giebułtowic et al. 2020 sludge
Yang et al. 2019 activated sludge
Fernandez-Fontaina et al. 2012b activated sludge
Abegglen et al. 2009 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Radjenovic et al. 2009 activated sludge
Joss et al. 2006 activated sludge
Gobel et al. 2005 activated sludge
Hyland et al. 2012 activated sludge
Hörsing et al. 2011 primary sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Hörsing et al. 2011 secondary sludge, short sludge age
Giebułtowic et al. 2020 sludge
Fernandez-Fontaina et al. 2012b activated sludge
Stevens-Garmon et al. 2011 activated sludge
Hyland et al. 2012 activated sludge
Gobel et al. 2005 activated sludge
Xue et al. 2010 activated sludge
Radjenovic et al. 2009 activated sludge
Abegglen et al. 2009 activated sludge
Jones et al. 2002 sludge
Yang et al. 2019 activated sludge
Fernandez-Fontaina et al. 2012b activated sludge
Abegglen et al. 2009 activated sludge
Ternes et al. 2004 activated sludge
Wick et al. 2009 activated sludge
Urase and Kikuta 2005 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Hyland et al. 2012 activated sludge
Radjenovic et al. 2009 activated sludge
Hörsing et al. 2011 primary sludge
Stevens-Garmon et al. 2011 activated sludge
Hyland et al. 2012 activated sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Stevens-Garmon et al. 2011 activated sludge
Abegglen et al. 2009 activated sludge
Hörsing et al. 2011 secondary sludge, short sludge age
Jones et al. 2002 sludge
Wick et al. 2009 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Radjenovic et al. 2009 activated sludge
Methadone 1.8808 Wick et al. 2009 activated sludge
Hörsing et al. 2011 primary sludge
Ternes et al. 2004 activated sludge
Wick et al. 2009 activated sludge
Hyland et al. 2012 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Hörsing et al. 2011 secondary sludge, long sludge age
Stevens-Garmon et al. 2011 activated sludge
Hörsing et al. 2011 secondary sludge, short sludge age
Stevens-Garmon et al. 2011 activated sludge
Munoz et al. 2009 activated sludge
Hyland et al. 2012 activated sludge
Atorvastatin 1.9685-2.2967 Stevens-Garmon et al. 2011 activated sludge
TCEP 1.8129-2.3636 Stevens-Garmon et al. 2011 activated sludge
TCPP
TDCPP
Hyland et al. 2012 activated sludge
Stevens-Garmon et al. 2011 activated sludge
Xue et al. 2010 activated sludge
Stevens-Garmon et al. 2011 activated sludge




























APPENDIX B: Supplemental Information for Chapter 2 
 
Table B1.1: The detections for specific compounds for the WWTFs sampled (indicated by their secondary treatment 
processes), including aqueous and solid phases, and surface water detections.  A red Asterix indicates that a compound 
is frequently detected in the environment.  Inf indicates an influent sample, while eff indicates an effluent sample.  BL 
indicates a potential lab blank concentration.  While indicates a compound was note detected in a specific sample, 
blue indicates a compound was detected and blue indicates a decreased concentration from influent to effluent.  Red 
in indicative of an increased concentration of a compound from effluent to influent, which may be described as 
“negative removal.” Table sourced from Hidrovo et al. (2020). 
 
 
Table B1.2: Concentrations (in ng/L) of PPCPs detected in surface water locations sampled in March, July, and 











Sludge Sludge Sludge Sludge

































































































Sulfamethoxazole 5.8 3.6 1.1
Trimethoprim 3.5
Carbamazepine 2.8 4.5 2.1
Phenytoin
Primidone







TCPP 22.0 39 16.0 16.0 14.0 28.0
TDCPP 3.9 18 1.9 2.1 3.8
Insectict Repellent DEET 8.5 29 15.0 16.0 16.0 28.0
Stimulant Caffeine 60.0 17 140.0 120.0 63.0 150.0


























Table B1.3: Detection concentrations for the five PPCPS detected in surface water locations in the year of 2020.  GBE 
indicates the Great Bay Estuary.  A dash indicates that a compound was not detected at a specific location. 
 
 
Table B1.4:  Subset of the antibiotics in focus for this study, and their common medical applications. 
 
 
Table B1.5: Water quality field parameters taken at each surface water sampling location, including one field blank, 
at the start and end of sampling.  Parameters measured include pH, redox potential, conductivity, dissolved oxygen 




Class Analyte Hilton GBE Squamscott
Clarithromycin - - 1.6
Sulfamethoxazole 1.25 0.985 11.6
Anti-convulsant Carbamazepine - - 8.48
Calcium Channel Blocker Diltiazem - - 1.03
Antihistamine Diphenhydramine - 0.653 1.47
Antibiotics
General Name Medical Usage Source
Ear, nose, and throat infections National Library of Medicine
Genitourinary tract infecftions National Library of Medicine
Skin infections National Library of Medicine
Lower respiratory tract infections National Library of Medicine
Skin infections Clinical Info.HIV.gov
Acute bacterial sinitis Clinical Info.HIV.gov
Chronic bronchitis Clinical Info.HIV.gov
Community-acquired pneumonia Clinical Info.HIV.gov
Pharyngitis/tonsillitis Clinical Info.HIV.gov, National Library of Medicine
Acute otitis media (ear infection) National Library of Medicine
Urinay Tract Infections Clinical Info.HIV.gov
Skin infections Clinical Info.HIV.gov
Lower respiratory tract infections Clinical Info.HIV.gov
Anthrax National Library of Medicine
Plague National Library of Medicine
Cholera National Library of Medicine
Bacterial Mengitis National Library of Medicine
Pharyngitis Clinical Info.HIV.gov
Acute sinus infection Clinical Info.HIV.gov
Aommunity-acquired pneumonia Clinical Info.HIV.gov
Mycobacterium avium complex (MAC) Clinical Info.HIV.gov
Respiratory tract infections National Library of Medicine
Skin, soft-tissue infections National Library of Medicine
Urinary infectinos National Library of Medicine
Respiratory infections National Library of Medicine
Gastrointestinal tract infections National Library of Medicine






Location pH Redox (mV) Conductivity (uS/cm) DO (% saturation) DO (mg/L) Temperature (°C) pH Redox (mV) Conductivity (uS/cm) DO (% saturation) DO (mg/L) Temperature (°C)
Hilton Park 7.96 -69.9 44.22 84.3 6.3 22.5 8.17 -82.9 44.34 73.3 5.45 22.5
Mill Pond 8.02 -73.2 149.1 22.3 4.27 21.7 8.02 -73.5 151.5 84 4.23 22.7
Adams Point 8.06 -75.8 42.65 85 6.24 23.6 8.09 -77.9 42.91 81.2 5.92 24
Great Bay Estuary 8.08 -76 137.1 86.5 4.32 24.4 8.16 -81.2 42.5 82.1 6.03 23.7
Squamscott 7.21 -27.5 29.11 63.5 4.27 24.6 7.25 -29.3 29.05 59.9 4.23 25.5
Field Blank 6.1 37.4 36.17 76.4 5.92 29.1 6.25 28.9 35.18 80.6 6.22 29.5








Table B1.6: The water quality measurements for each surface water sample, including field and blanks, for ammonia 







































Location Ammonia, Nitrogen (mg/L) Chemical Oxygen Demand (mg/L) Orthophosphate (mg/L)
Hilton Park 0.0695 68.8 0.080
Mill Pond 0.106 69.9 0.060
Adams Point 0.0585 79.5 0.030
Great Bay Estuary 0.0697 59.1 0.060
Squamscott 0.157 30.7 0.070
Field Blank -0.005000 -79.2 0.025
Lab Bank -0.00133 -22.4 -
Standard 10.3 81.6 -
Detection limit 1-12 mg/L NH3-N 3-150 mg/L COD 0.02-2.50 mg/L PO4 3-
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APPENDIX C: Supplemental Information for Chapter 3 
 
Table C1.1: The average detected concentrations of pharmaceuticals and personal care products and the average 
parts per billion (PPB) concentrations of pharmaceuticals and personal care products in aqueous and sludge samples.  




Table C1.2: The detections for secondary influent (Sin), secondary effluent (Sout), chlorination (chl), dechlorination 
(Dchl), and sludge (SLG) for each WWTF.  Aqueous detections presented in ng/L and sludge detections presented in 
ug/kg.  An orange box indicates the detection of a specific compound for a sample, and a gray box with “BDL” 


























PPCP Group Secondary Influent (ng/L) Secondary Effluent (ng/L) Chlorination (ng/L) Dechlorination (ng/L) Sludge (ug/kg)
Pharmaceuticals 4868 367.3 77.86 88.82 23.36
Personal Care Products 9217 668.4 373.2 356.2 42.72
PPCP Group Secondary Influent (PPB) Secondary Effluent (PPB) Chlorination (PPB) Dechlorination (PPB) Sludge (PPB)
Pharmaceuticals 0.487 0.0367 0.007786 0.008882 2.336
Personal Care Products 0.922 0.0668 0.03732 0.03562 4.272
Average Detected Concentration Across Wastewater Treatment Facilities
Average Concentration by Weight Across Wastewater Treatment Facilities
Sin Sout Chl Dchl SLG Sin Sout Chl Dchl SLG Sin Sout Chl Dchl SLG Sin Sout Chl Dchl SLG
Analgesic Acetaminophen 190000 BDL BDL BDL BDL 16000 BDL BDL BDL BDL 29000 BDL BDL BDL BDL 22000 BDL BDL BDL BDL
Amoxicillin BDL BDL BDL BDL BDL 0 BDL BDL BDL BDL 9400 830 BDL BDL BDL 6000 3500 BDL BDL BDL
Azithromycin BDL BDL BDL 87 BDL 140 BDL 20 BDL BDL BDL 200 140 150 BDL 350 250 170 260 18
Ciprofloxacin BDL 4000 BDL 19 18 46 4400 10 BDL 580 690 130 30 41 44 1200 300 38 66 580
Sulfamethoxazole 97 500 8 17 BDL 590 330 5 14 BDL 340 540 250 250 1.4 2500 410 540 370 BDL
Trimethoprim 92 650 0 0 BDL 140 260 BDL BDL BDL 86 170 88 100 8.6 470 270 150 140 7.6
Carbamazepine 2500 490 300 320 BDL 73 120 68 67 BDL 350 220 230 270 2.1 920 760 850 820 6
Phenytoin (Dilantin) BDL BDL 59 91 BDL 19 BDL 11 BDL 1.1 76 BDL BDL 130 2.9 150 210 79 120 BDL
Primidone BDL BDL 110 110 BDL 170 BDL 78 60 BDL 160 57 67 61 BDL 260 69 140 97 BDL
B-BDLocker Atenolol 2100 BDL 150 170 BDL 570 BDL 240 230 BDL 1700 110 160 190 BDL 1500 90 220 280 BDL
 Narcotic Methadone BDL BDL 2 2 BDL 2.7 BDL 1.2 BDL BDL 110 97 66 78 3.1 55 57 46 57 1.9
Diazepam BDL BDL BDL BDL BDL 3.8 BDL 1.7 1.6 BDL BDL 1.3 BDL BDL BDL BDL BDL BDL BDL BDL
Meprobamate BDL 0 6 130 BDL 79 BDL 8.7 22 BDL 130 16 23 21 BDL 11 2.6 3.1 47 0
SSRI Fluoxetine BDL 1400 31 71 8 46 500 31 44 21 150 96 73 81 49 220 160 130 200 49
Statin Atorvastatin 390 120 1 BDL BDL 79 280 BDL BDL BDL 720 120 18 15 BDL 400 320 19 30 BDL
TCEP 64 220 58 43 BDL 80 BDL 37 51 BDL 51 45 48 42 BDL 230 81 85 67 BDL
TCPP 1200 2100 2100 1500 68 2100 1400 1000 1300 150 12000 1400 1300 1200 260 1300 1400 1600 1800 230
TDCPP 500 3400 410 430 13 180 1200 210 150 19 520 400 480 490 100 1500 600 790 880 84
Insect Repellent DEET 1700 140 100 110 1 1600 330 120 150 1 6500 69 110 40 4.2 9600 69 67 73 17
Stimulant Caffeine 26000 100 64 55 BDL 28000 1700 25 23 5 68000 45 250 23 42 58000 28 23 22 31
Tobacco metabolite Cotinine 880 480 31 12 BDL 160 710 6.4 12 BDL 600 84 43 51 BDL 440 41 BDL 24 0










































Table C1.3: WWTF 1 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent 
abundance by weight in sludge.  BDL indicates a specific analyte was below the detection limit.  Numbers in red 
indicate blank contamination.  Atomic masses retrieved from PubChem (PubChem 2021). 
 
 
Table C1.4: WWTF 2 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent 
abundance by weight in sludge.  BDL indicates a specific analyte was below the detection limit.  Numbers in red 
indicate blank contamination.  Atomic masses retrieved from PubChem (PubChem 2021). 
 
 
Acetaminophen BDL 151.16 0 0
Amoxicillin BDL 365.4 0 0
Azithromycin BDL 749 0 0
Ciprofloxacin 44 331.34 1.328E-07 11.49
Sulfamethoxazole 1.4 253.28 5.527E-09 0.4782
Trimethoprim 8.6 290.32 2.962E-08 2.563
Carbamazepine 2.1 236.27 8.888E-09 0.7690
Phenytoin (Dilantin) 2.9 252.27 1.150E-08 0.9946
Primidone BDL 218.25 0 0
Atenolol BDL  266.34 0 0
Methadone 3.1 309.4 1.002E-08 0.8668
Diazepam BDL  284.74 0 0
Meprobamate BDL 218.25 0 0
Fluoxetine 49 309.33 1.584E-07 13.70
Atorvastatin BDL 558.6 0 0
TCEP BDL 250.19 0 0
TCPP 260 790.8 3.288E-07 28.44
TDCPP 100 430.9 2.321E-07 20.08
DEET 4.2 191.27 2.196E-08 1.900
Caffeine 42 194.19 2.163E-07 18.71









Acetaminophen BDL 151.16 0 0
Amoxicillin BDL 365.4 0 0
Azithromycin BDL 749 0 0
Ciprofloxacin 44 331.34 1.328E-07 11.49
Sulfamethoxazole 1.4 253.28 5.527E-09 0.4782
Trimethoprim 8.6 290.32 2.962E-08 2.563
Carbamazepine 2.1 236.27 8.888E-09 0.7690
Phenytoin (Dilantin) 2.9 252.27 1.150E-08 0.9946
Primidone BDL 218.25 0 0
Atenolol BDL  266.34 0 0
Methadone 3.1 309.4 1.002E-08 0.8668
Diazepam BDL  284.74 0 0
Meprobamate BDL 218.25 0 0
Fluoxetine 49 309.33 1.584E-07 13.70
Atorvastatin BDL 558.6 0 0
TCEP BDL 250.19 0 0
TCPP 260 790.8 3.288E-07 28.44
TDCPP 100 430.9 2.321E-07 20.08
DEET 4.2 191.27 2.196E-08 1.900
Caffeine 42 194.19 2.163E-07 18.71










Table C1.5: WWTF 3 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent 
abundance by weight in sludge.  BDL indicates a specific analyte was below the detection limit.  Numbers in red 
indicate blank contamination.  Atomic masses retrieved from PubChem (PubChem 2021). 
 
 
Table C3.6: WWTF 1 sludge PPCP detections, atomic mass of PPCPs, average by atomic weight, and percent 
abundance by weight in sludge.  BDL indicates a specific analyte was below the detection limit.  Numbers in red 
indicate blank contamination.  Atomic masses retrieved from PubChem (PubChem 2021). 
 
 
Acetaminophen BDL 151.16 0 0
Amoxicillin BDL 365.4 0 0
Azithromycin 18 749 2.403E-08 8.819E-01
Ciprofloxacin 580 331.34 1.750E-06 64.24
Sulfamethoxazole BDL 253.28 0 0
Trimethoprim 7.6 290.32 2.618E-08 0.9607
Carbamazepine 6 236.27 2.539E-08 0.9319
Phenytoin (Dilantin) BDL 252.27 0 0
Primidone BDL 218.25 0 0
Atenolol BDL  266.34 0 0
Methadone 1.9 309.4 6.141E-09 0.2254
Diazepam BDL  284.74 0 0
Meprobamate BDL 218.25 0 0
Fluoxetine 49 309.33 1.584E-07 5.813
Atorvastatin BDL 558.6 0 0
TCEP BDL 250.19 0 0
TCPP 230 790.8 2.908E-07 10.67
TDCPP 84 430.9 1.949E-07 7.154
DEET 17 191.27 8.888E-08 3.262
Caffeine 31 194.19 1.596E-07 5.858
Cotinine BDL 176.21 0 0
TOTAL: 2.725E-06
WWTF 3Compound Percent Abundance 
by Weight




Acetaminophen BDL 151.16 0 0
Amoxicillin BDL 365.4 0 0
Azithromycin BDL 749 0 0
Ciprofloxacin 18 331.34 5.432E-08 26.84
Sulfamethoxazole BDL 253.28 0 0
Trimethoprim BDL 290.32 0 0
Carbamazepine BDL 236.27 0 0
Phenytoin (Dilantin) BDL 252.27 0 0
Primidone BDL 218.25 0 0
Atenolol BDL  266.34 0 0
Methadone BDL 309.4 0 0
Diazepam BDL  284.74 0 0
Meprobamate BDL 218.25 0 0
Fluoxetine 8 309.33 2.619E-08 12.94
Atorvastatin BDL 558.6 0 0
TCEP BDL 250.19 0 0
TCPP 68 790.8 8.599E-08 42.48
TDCPP 13 430.9 3.017E-08 14.90
DEET 1 191.27 5.751E-09 2.841
Caffeine BDL 194.19 0 0











Figure C3.1: A correlation analysis comparing secondary effluent concentrations of 
carbamazepine (ng/L) versus secondary effluent pH levels in the four WWTFs sampled.  R2 value 






































Secondary Effluent Concentration (ng/L)
Carbamazepine
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APPENDIX D: Supplemental Information for Chapter 4 
 
Table D1.1: The 21 PPCPs screened in our analysis and their detections in each wastewater sample analyzed, in ng/L.  
WWTF is indicated by the number in front of the sample ID. 
 
 
Table D1.2: The number of ‘hits’ and percent abundances identifying as Archaea, 
Bacteria, and Unassigned from 16s rRNA Sequencing. 
 
 
Table D1.3: The number of ‘hits’ and percent abundances identifying as Archaea, 


























Sample ID Acetaminophen Atorvastatin Meprobamate Phenytoin (Dilantin) Ciprofloxacin TCEP Azithromycin Primidone Atenolol Sulfamethoxazole Fluoxetine Amoxicillin Caffeine Trimethoprim Carbamazepine Diazepam TCPP Cotinine DEET TDCPP Methadone
1-Sin 190000 0 0 0 97 92 2500 0 0 2100 0 0 0 0 390 64 1200 500 1700 26000 880
1-Sout 0 0 0 4000 500 650 490 0 0 0 0 0 0 1400 120 220 2100 3400 140 100 480
1-SLG 0 0 0 18 0 0 0 0 0 0 0 0 0 8 0 0 68 13 1 0 0
2-Sin 16000 0 140 46 590 140 73 19 170 570 2.7 3.8 79 46 79 80 2100 180 1600 28000 160
2-Sout 0 0 0 4400 330 260 120 0 0 0 0 0 0 500 280 0 1400 1200 330 1700 710
2-SLG 0 0 0 580 0 0 0 1.1 0 0 0 0 0 21 0 0 150 19 1 5 0
3-Sin 29000 9400 0 690 340 86 350 76 160 1700 110 0 130 150 720 51 12000 520 6500 68000 600
3-Sout 0 830 200 130 540 170 220 0 57 110 97 1.3 16 96 120 45 1400 400 69 45 84
3-SLG 0 0 0 44 1.4 8.6 2.1 2.9 0 0 3.1 0 0 49 0 0 260 100 4.2 42 0
4-Sin 22000 6000 350 1200 2500 470 920 150 260 1500 55 0 11 220 400 230 1300 1500 9600 58000 440
4-Sout 0 3500 250 300 410 270 760 210 69 90 57 0 2.6 160 320 81 1400 600 69 28 41
4-SLG 0 0 18 580 0 7.6 6 0 0 0 1.9 0 0 49 0 0 230 84 17 31 0
PPCP Detected (ng/L)
WWTF Archaea Bacteria Unassigned Archaea Bacteria Unassigned
WWTF 1 0 30893 8 0 99.9741109 2.5889E-06
WWTF 2 0 20771 0 0 100 0
WWTF 3 0 39493 18 0 99.9544431 4.5557E-06
WWTF 4 11 48166 21 0.02282252 99.9336072 4.357E-06
Number of Sequence 'Hits' Percent Abundance
WWTF Archaea Bacteria Eukaryota Viruses Other Archaea Bacteria Eukaryota Viruses Other
WWTF 1 46443 8562026 76013 2861 661 0.534564671 98.54997765 0.874919026 0.032930464 0.007608192
WWTF 2 38437 7146595 87099 3451 528 0.528263042 98.21999667 1.19705447 0.047429189 0.007256625
WWTF 3 45437 7666618 86261 3027 564 0.582383256 98.26594959 1.105639942 0.038798207 0.007229002
WWTF 4 45162 8501492 84546 3837 715 0.522965458 98.44530042 0.97902302 0.044431568 0.008279534
Number of Sequence 'Hits' Percent Abundance
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Table D1.4: The dimensions and NMDS values calculated from an NMDS in 
R studio evaluating the microbial classes within each WWTF sample. 
 
 
Table D1.5:The water quality parameters for secondary influent and secondary effluent samples at each WWTF.  
WWTF is indicated by the number in front of the sample ID.  DO=dissolved oxygen, REDOX=oxidation reduction 
potential, Temp=temperature, COD=chemical oxygen demand, NPOC=non-purgeable organic carbon, TDN=total 













WWTF ID ID Dim1 Dim2 NMDS1 NMDS2
1 Sin -0.2352465 -0.2021096 -1.258719176 0.04341799
1 Sout -0.3095274 -0.2090716 0.267959775 -0.17400149
1 Sludge -0.2858866 -0.2297647 0.241556513 -0.14311801
1 BH -0.2904855 -0.2179615 0.255752811 -0.16929968
1 AH -0.2917918 -0.2152291 0.21850501 -0.15637172
2 Sin -0.2591534 -0.2371745 -0.505821548 0.42399761
2 Sout 7.3734571 5.478038 -0.086544094 -0.33609144
2 Z1 -0.286258 -0.2075814 0.076903132 0.23182328
2 Z2 -0.3206816 -0.2385042 0.075529355 0.07391132
2 Z3 -0.3067278 -0.2292846 0.120943868 0.23100353
2 Z4 -0.3103297 -0.2271139 0.167135196 0.21542487
2 Sludge -0.2929518 -0.2336118 0.003347266 0.52616443
3 Sin -0.2439664 -0.2679149 -1.187532811 -0.09921475
3 Sout -0.3236393 -0.2093939 0.310999944 -0.08081971
3 Z1 -0.2914827 -0.2067715 0.363490041 -0.07880531
3 Z2 -0.3040896 -0.2198512 0.397694021 -0.10747243
3 Z3 -0.3121793 -0.2199938 0.324216884 -0.11114889
3 Z4 -0.3056802 -0.2041389 0.344394582 -0.10611917
3 Sludge -0.3420225 -0.1637471 -0.006830318 -0.73666248
4 Sin -0.2630175 -0.1987787 -1.207862081 -0.18184885
4 Sout -0.302574 -0.2147509 0.227308256 0.08734252
4 Z1 -0.303276 -0.2067287 0.30109154 0.14550154
4 Z2 -0.2963754 -0.2268361 0.24746239 0.12008626
4 Z3 -0.3246966 -0.2401997 0.263773745 0.11348469
4 Z4 -0.2995398 -0.2195295 0.260816629 0.14865617
4 Sludge -0.2718777 -0.2319962 -0.21557093 0.12015973
Sample ID pH Conductivity DO REDOX Temp COD Ammonia NPOC TDN
1-Sin 7.7 885.1 4.4 -34.4 20.6 288.5 44.5 42.4 44
1-Sout 7 731.1 0.3 -4 22.5 16.4 1 5.3 12.4
2-Sin 7.3 839.2 4.2 -22.5 22.8 88.2 30.7 26.9 31
2-Sout 6.5 667.2 1 26.8 23.9 24.3 1 7.3 3.1
3-Sin 7.5 877.6 1.6 -31.3 21.3 182.4 38.6 40.3 37.8
3-Sout 6.7 755.8 0.9 14.5 22.2 36.6 1 8.8 3.7
4-Sin 7.3 1124 2.1 -22.1 23 314.3 51.5 54.4 46.1
4-Sout 6.6 816.7 1.9 18.7 23.5 19.8 1 6.4 3.4
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Table D1.6: The different diversity indices calculated for each WWTF sample, including Inverse Simpson’s Index, 




















WWTF ID Sample ID Inverse Simpson Simpson's Evenness Shannon Diversity Species Richness Chao1
WWTF 1 Sin 15.58791577 0.115466043 3.637568742 135 135.0625
WWTF 1 Sout 51.22982494 0.209101326 4.533415789 245 245.9
WWTF 1 Sludge 56.96741655 0.210211869 4.651080863 271 271.25
WWTF 1 BH 52.28669605 0.199567542 4.584232908 262 262.2857143
WWTF 1 AH 51.24929844 0.223796063 4.533402047 229 229
WWTF 2 Sin 57.63101904 0.206562792 4.66250634 279 280.1428571
WWTF 2 Sout 23.44197195 0.384294622 3.611035707 61 61
WWTF 2 Z1 59.09100651 0.193107864 4.814455297 306 307.6
WWTF 2 Z2 50.90739045 0.253270599 4.534121194 201 201
WWTF 2 Z3 55.98038497 0.196422403 4.749133266 285 285.125
WWTF 2 Z4 54.76503647 0.19351603 4.737941472 283 283.6666667
WWTF 2 Sludge 68.92579182 0.225247686 4.93443311 306 306.125
WWTF 3 Sin 17.50520847 0.103581115 3.805132236 169 169
WWTF 3 Sout 36.9069196 0.194246945 4.271979818 190 190
WWTF 3 Z1 35.96081933 0.131243866 4.42097523 274 275
WWTF 3 Z2 37.7174655 0.152702289 4.377420737 247 247.6666667
WWTF 3 Z3 35.82344194 0.143869245 4.370099215 249 250
WWTF 3 Z4 34.8654704 0.170909169 4.252033109 204 204.5
WWTF 3 Sludge 10.45788041 0.052029256 3.570429908 201 201.1
WWTF 4 Sin 22.63444143 0.117276899 4.039439037 193 193
WWTF 4 Sout 45.8315644 0.186307172 4.54676569 246 246.5
WWTF 4 Z1 36.26168444 0.163340921 4.412409834 222 222.25
WWTF 4 Z2 34.82509798 0.168237188 4.355714554 207 207.25
WWTF 4 Z3 34.89642225 0.182703781 4.343666272 191 191.4
WWTF 4 Z4 41.74048164 0.172481329 4.505254959 242 242.5
WWTF 4 Sludge 78.09797085 0.261197227 4.895878536 299 299.2222222
NA NEG CON 76.77456955 0.347396242 4.844548353 221 221
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Table D1.8: The percent removal of four target PPCPs in the four WWTFs sampled. 
 
Enzyme Class WWTF1 WWTF2 WWTF3 WWTF4
Allantoicase 0.01573789 0.02678029 0.03014213 0.03662128
Amidase 0.33563604 0.31330422 0.37401424 0.31816055
Arginase 0.04457309 0.04512353 0.04358828 0.04614704
ATPase 1.01866753 0.99494239 1.05469009 1.03167564
Carboxylase 1.0491575 1.06978449 1.0883664 1.07743459
Decarboxylase 0.79192924 0.81600135 0.81119695 0.82891797
Gutamase 0.01295647 0.01150125 0.01466484 0.01150148
Halogenase 0.04386893 0.04134575 0.04988481 0.04032574
Helicase 1.56537439 1.62461503 1.62763424 1.65578965
Hydratase 3.1935243 3.08850634 3.04459857 2.96921626
Hydrogenase 10.2276924 9.88851759 9.99142452 9.89825777
Hydrolase 0.77136788 0.74905062 0.75558432 0.72212355
Hydroxylase 0.21254954 0.19871144 0.17406875 0.20014691
Isomerase 1.09957508 1.11205369 1.11903662 1.04861033
Kinase 4.73714026 4.88123277 4.89984242 4.8171794
Kynureninase 0.07854862 0.07526185 0.07576155 0.08573189
Ligase 1.8427063 1.83075612 1.79252223 1.86962544
Lyase 1.29441509 1.27575767 1.230465 1.27969834
Mannosidase 0.06362051 0.05914331 0.08567351 0.05143913
Minase 0.84122018 0.81709271 0.83228019 0.81879243
Multiple 1.69926968 1.73622756 1.69730236 1.79842917
Other 32.2585211 32.945299 32.9695561 32.8014781
Oxidase 1.87059088 1.80649435 1.94879819 1.90631728
Oxygenase 0.84354389 0.80831986 0.76919296 0.84243044
Peptidase 0.96909494 0.95288306 0.99062791 0.99039732
Permease 2.84510782 2.74858973 2.70795732 2.59280741
Phosphatase 1.19935401 1.21136744 1.24001136 1.27059594
Reductase 5.52537268 5.50477701 5.45604998 5.53108257
Synthase 8.26383605 8.17986785 8.15068301 8.25513386
Synthetase 5.98208838 6.05394088 5.92268423 5.99534014
Tinase 0.07488701 0.05792602 0.07133366 0.06191747
Transferase 9.22701608 9.07385946 8.9774385 9.14512256
Tyrosinase 0.00105623 0.00096543 0.00292484 0.00155235
PPCP WWTF 1 WWTF 2 WWTF 3 WWTF 4
Carbamazepine -415.5 44.07 -58.82 83.60
DEET 91.76 79.38 98.94 99.28
Sulfamethoxazole 80.40 -64.38 37.14 17.39
Caffeine 99.62 93.93 99.93 99.95
Percent Removal
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Table D1.9: The microbial phyla detected in each WWTFs, according to MG-RAST RefSeq Database.
 
 
Label WWTF 1 WWTF 2 WWTF 3 WWTF 4
Proteobacteria 52.48533495 59.30079397 53.85412823 61.13414327
Actinobacteria 17.31033964 9.211666674 7.620854747 7.27480363
Bacteroidetes 13.30363108 14.2985194 17.85019996 15.62629404
Firmicutes 3.063488461 3.220718213 3.306371122 2.858372959
Planctomycetes 2.118887146 1.615492344 2.213715185 1.666629611
Chloroflexi 1.723387788 2.328854292 4.61469228 1.546651641
Nitrospirae 1.608839038 0.161611081 0.58162703 1.023790401
Cyanobacteria 1.576058206 1.615725985 1.987924234 1.585976531
Acidobacteria 1.29242574 1.181579168 1.287210934 1.119578237
Verrucomicrobia 1.263063415 2.574796148 2.120250857 1.879720492
Chlorobi 0.534725813 0.576599309 0.586087478 0.622169326
Deinococcus-Thermus 0.496086328 0.461235468 0.539304045 0.423819489
Euryarchaeota 0.469003007 0.468107272 0.513348852 0.460041002
Gemmatimonadetes 0.388627814 0.365868575 0.363526507 0.393167845
Spirochaetes 0.241298231 0.351231633 0.296055823 0.287571945
unclassified (derived from Bacteria) 0.225978257 0.199763335 0.187044014 0.188055424
Chlamydiae 0.160819447 0.081939388 0.147681842 0.10507481
Streptophyta 0.151093393 0.179024231 0.175495555 0.164096885
Ascomycota 0.14800868 0.167960627 0.16916377 0.140798393
Chordata 0.145372861 0.22157444 0.175751903 0.199276218
Aquificae 0.130225539 0.121287336 0.122931483 0.133178906
Thermotogae 0.128717712 0.122043235 0.137415122 0.118252585
Candidatus Poribacteria 0.113133005 0.017495612 0.045373522 0.070381827
unclassified (derived from Eukaryota) 0.112465418 0.207927038 0.21630609 0.117256725
Cnidaria 0.098860452 0.135704381 0.097245456 0.117152507
Fusobacteria 0.088800604 0.09074904 0.094169285 0.081984754
Synergistetes 0.070499507 0.072703684 0.070662211 0.068065873
Arthropoda 0.063432291 0.080372617 0.079967628 0.077225469
Deferribacteres 0.060923084 0.059825923 0.059113753 0.061291709
Crenarchaeota 0.053453014 0.04910591 0.054396957 0.049607724
Chlorophyta 0.052371062 0.070944502 0.059062483 0.05777146
Lentisphaerae 0.052232941 0.072621222 0.06518919 0.061303289
Dictyoglomi 0.03446131 0.029699936 0.034812002 0.028104096
Basidiomycota 0.033736172 0.036379329 0.039695423 0.02988738
unclassified (derived from Viruses) 0.032930464 0.047429189 0.038798207 0.044431568
Nematoda 0.025368312 0.031912657 0.033568716 0.023946959
Chrysiogenetes 0.023457632 0.024504852 0.02494262 0.02589236
Tenericutes 0.020108186 0.023680236 0.01775207 0.020079317
Elusimicrobia 0.017875222 0.016437355 0.018277583 0.023240593
Fibrobacteres 0.016551558 0.02255326 0.018636469 0.017705464
Bacillariophyta 0.012569055 0.017110791 0.014201656 0.012587207
Apicomplexa 0.011659755 0.020807822 0.019674677 0.014277853
unclassified (derived from other sequences) 0.007608192 0.007256625 0.007229002 0.008279534
Thaumarchaeota 0.007516111 0.007215394 0.009215696 0.009379612
Echinodermata 0.006721912 0.008947088 0.008446653 0.008603767
Placozoa 0.005145025 0.006761855 0.00635742 0.00646151
Korarchaeota 0.004523479 0.003532107 0.005229491 0.003670786
Hemichordata 0.002612798 0.00449416 0.004306639 0.004249775
Microsporidia 0.00185313 0.001992823 0.001986694 0.001875922
Platyhelminthes 0.001657458 0.002652516 0.002255859 0.002292794
Chytridiomycota 0.000828729 0.000233641 0.000128174 0.000370553
unclassified (derived from Fungi) 0.000310773 0.000659693 0.000820312 0.000196856
Phaeophyceae 0.000264733 0.000659693 0.000281982 0.000162117
Blastocladiomycota 0.000172652 0.000302359 0.000358887 3.47393E-05
Porifera 0.000126611 0.000178667 0.000128174 5.78988E-05
Glomeromycota 9.2081E-05 9.62053E-05 0.000115356 1.15798E-05
Nanoarchaeota 6.90607E-05 0.000302359 0.000192261 0.000266335
Rotifera 4.60405E-05 9.62053E-05 0.000179443 0.000277914
Euglenida 4.60405E-05 6.8718E-05 7.69043E-05 8.10584E-05
Chromerida 3.45304E-05 4.12308E-05 1.28174E-05 1.15798E-05
Mollusca 2.30202E-05 5.49744E-05 3.84521E-05 2.31595E-05
Xanthophyceae 1.15101E-05 6.8718E-05 1.28174E-05 1.15798E-05
Sipuncula 1.15101E-05 0.0000000 0.0000000 0.0000000
Brachiopoda 1.15101E-05 0 0 2.31595E-05
Annelida 1.15101E-05 2.74872E-05 0 0
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Figure D1.1: Non-metric multidimensional scaling stress plot (A), MDS plot (B), ordiplot (C), MDS plot overlay (D) 
for 16S rRNA microbial classes, extracted from R Studio (Version 1.3.1073). 
 
 
Figure D1.2: Non-metric multidimensional Scaling plots showing the influence of water quality parameters (A) and 




Figure D1.3: Correlation analysis of percent carbamazepine removal versus percent enzyme abundance of two 
carbamazepine-degrading enzymes, catechol 1,2 dioxygenase and catechol 2,3 dioxygenase. 
 
 
Figure D1.4: Correlation analysis of percent DEET removal versus percent enzyme abundance of one DEET-















































Figure D1.5: Correlation analysis of percent sulfamethoxazole removal versus percent enzyme abundance of one 
sulfamethoxazole-degrading enzyme, arylamine N-acetyltransferase. 
 
 
Figure D1.6: Correlation analysis of percent caffeine removal versus percent enzyme abundance of one caffeine-














































NMDS on Microbial Phyla: Procedure 
 
###Carmela Antonellis### 
#MS THESIS_NMDS_Phyla & PPCPs 
#Input Data files: PhylaSubSam_Sec.csv 
#                  PhylaSubSamTrans_Sec.csv 
#                  EnvPPCP.csv 
 
##NMDS with PPCPs - adjusted from Mouser code 
##Using secondary in and out, and sludge microbial phylum data along with the PPCPs at each 
sample point 
 













Alldata=read.csv("PhylaSubSam_Sec.csv", row.names=1, header=TRUE) #loading the microbial 
data 
#This is what the file look like-how the data was organized: 
 
 
Alldatat=read.csv("PhylaSubSamTrans_Sec.csv",row.names=1,header=TRUE) #loading the 
transposed microbial data 




Envdata=read.csv("EnvPPCP.csv",header=TRUE) #loading the environmental data (in this case 
PPCP data) 




dim(Alldata) #finding the dimensions of the microbial data 
dim(Envdata) #finding the dimensions of the environmental (PPCP) data 
 
# Inverse of Simpson's Diversity Index, returns "1/D" 
invsimpson=diversity(Alldata,index="invsimpson") #calculating the Inverse Simpson's index 
write.table(invsimpson, file="InvSimpson_Species_042221.xls", row.names=TRUE, sep="/t") 
  #exporting the inverse Simpsons index results as an excel spreadsheet 
 
# Finding the Evenness: E 1/D  
IS=invsimpson  #Computes the inverse Simpson into a new matrix IS 
S=specnumber(Alldata) #Computes the species richness into a new matrix IS 
EIS=IS/S #dividing the inverse Simpsons by the species number, will give us the evenness 
EIS  #prints to screen the computed evenness 




write.table(EIS, file="Simpson_Evenness_Species_042221.xls", row.names=TRUE, sep="/t") 
#exporting table with simpsons evenness calculated 
write.table(S, file="Richness_Species_042221.xls", row.names=TRUE, sep="/t") #exporting file 
with species richness data calculated 
shannondiv=diversity(Alldata,index = "shannon") #calculating Shannon diversity of microbial 
data 
write.table(shannondiv, file="Shannon_Species_042221.xls", row.names=TRUE, sep="/t") 
#exporting the Shannon diversity values calculated 
shannondiv #asking R studio to display the Shannon diversity values (doing it here for 




#Now finding the Jaccard dissimilarity and Bray Curtis dissimilarity 
Alldata.bj=vegdist(Alldata,method="jaccard") #calculating Jaccard index 
Alldata.dis=vegdist(Alldata,method="bray") #calculating Bray Curtis distances 
Alldata.mdsO=isoMDS(Alldata.dis) #this is making an NMDS from the Bray-Curtis 
dissimilarity calculations 
scores(Alldata.mdsO) #viewing the scores on screen 
  ###AT THIS POING, PULLED OUT DATA INTO AN EXCEL SHEET, GIVING THE 
DIMENSIONS FOR THE BRAY CURTIS DISTANCES### 
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stressplot(Alldata.mdsO,Alldata.dis) #view stress plot of data 
  #What stress plot diplays: 
 
ordiplot(Alldata.mdsO,type="t") #Gives me statement "species scores not available", but still get 
a figure 
  #what ordiplot displays: 
 
#rotating to PC axes (principal component-basically formatting the dimensions and axes we 
want) 
AlldataPC.mds=metaMDS(Alldata,distance="bray",trace=FALSE,pc=TRUE) #running 
metaMDS function on data 
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scores(AlldataPC.mds) #viewing the results 




plot(AlldataPC.mds) #This will plot the species data on top of the ordination information 
  #output: 
 
plot(AlldataPC.mds,type="t") #this line of code will plot the phyla data on top of the ordination 
information 




#Now calculating the gradients associated with environmental factors 
  #when evaluating microbial data without environmental factors, leave these lines of code out of 
the analysis 
Envdata.vec=envfit(AlldataPC.mds,Envdata,perm=999,na.rm=TRUE)#setting up 999 
permutations 
#Now will view on screen: 
Envdata.vec #view the environmental factors, see what is significant (P value<0.05, also 
indicated by an Asterix in R studio) 
###AT THIS POINT, PULLED OUT THE ENVIRONMENTAL VECTORS FOR USE IN 
MATLAB### 





plot(AlldataPC.mds, display="site") #plotting the data 




plot(Envdata.vec,p.max=0.5) #plotting the environmental vectors on top 
#this plots all environmental factors, whether significant or not 




##End of NMDS code in R studio -- then imported the Bray-Curtis distances and 
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